Document and Entity Information
Document and Entity Information - $ / shares | 9 Months Ended | |
Sep. 30, 2017 | Nov. 03, 2017 | |
Details | ||
Registrant Name | INDEPENDENCE HOLDING COMPANY | |
Registrant CIK | 701,869 | |
SEC Form | 10-Q | |
Period End date | Sep. 30, 2017 | |
Fiscal Year End | --12-31 | |
Trading Symbol | ihc | |
Tax Identification Number (TIN) | 581,407,235 | |
Number of common stock shares outstanding | 14,862,346 | |
Filer Category | Accelerated Filer | |
Current with reporting | Yes | |
Voluntary filer | No | |
Well-known Seasoned Issuer | No | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2,017 | |
Document Fiscal Period Focus | Q3 | |
Entity Incorporation, State Country Name | Delaware | |
Entity Address, Address Line One | 96 CUMMINGS POINT ROAD | |
Entity Address, City or Town | STAMFORD | |
Entity Address, State or Province | CONNECTICUT | |
Entity Address, Postal Zip Code | 6,902 | |
City Area Code | 203 | |
Local Phone Number | 358-8000 | |
Entity Listing, Par Value Per Share | $ 1 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Sep. 30, 2017 | Dec. 31, 2016 |
Investments | ||
Short-term investments | $ 50 | $ 6,912 |
Securities Purchased under Agreements to Resell | 20,597 | 28,962 |
Trading Securities | 516 | 592 |
Available-for-sale Securities, Debt Securities | 426,000 | 449,487 |
Available-for-sale Securities, Equity Securities | 5,460 | 5,333 |
Other Investments | 18,338 | 23,534 |
Investments, Total | 470,961 | 514,820 |
Cash and Cash Equivalents, at Carrying Value | 26,565 | 22,010 |
Premiums Receivable, Net | 32,678 | 42,896 |
Reinsurance Recoverables, Including Reinsurance Premium Paid | 383,192 | 440,285 |
Customer Funds | 13,665 | 17,952 |
Goodwill | 50,697 | 41,573 |
Other Assets | 61,472 | 54,928 |
Assets, Total | 1,039,230 | 1,134,464 |
Liabilities | ||
Liability for Claims and Claims Adjustment Expense, Beginning Balance | 169,547 | 219,113 |
Liability for Future Policy Benefits | 217,415 | 219,450 |
Deposit Contracts, Liabilities | 143,637 | 145,749 |
Unearned Premiums | 7,993 | 9,786 |
Policyholder Funds | 10,249 | 9,769 |
Reinsurance Payable | 5,715 | 35,796 |
Other Liabilities | 59,747 | 55,477 |
Disposal Group, Including Discontinued Operation, Liabilities | 0 | 68 |
Liabilities, Total | 614,303 | 695,208 |
Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount | 2,035 | 0 |
TOTAL LIABILITIES AND EQUITY | 1,039,230 | 1,134,464 |
STOCKHOLDERS' EQUITY: | ||
Preferred Stock, Value, Issued | 0 | 0 |
Common Stock, Value, Issued | 18,625 | 18,620 |
Paid-in capital | 126,135 | 126,468 |
Accumulated other comprehensive loss | (2,344) | (6,964) |
Treasury stock, at cost; 3,716,941 and 1,517,983 shares | 61,712 | 17,483 |
Retained Earnings (Accumulated Deficit) | 339,512 | 315,918 |
TOTAL IHC STOCKHOLDERS' EQUITY | 420,216 | 436,559 |
NONREDEEMABLE NONCONTROLLING INTERESTS | 2,676 | 2,697 |
TOTAL EQUITY | $ 422,892 | $ 439,256 |
Condensed Consolidated Balance3
Condensed Consolidated Balance Sheets - Parenthetical - $ / shares | Sep. 30, 2017 | Dec. 31, 2016 |
Details | ||
Preferred Stock, Par or Stated Value Per Share | $ 1 | $ 1 |
Preferred Stock, Shares Authorized | 100,000 | 100,000 |
Preferred Stock, Shares Outstanding | 0 | 0 |
Common Stock, Par or Stated Value Per Share | $ 1 | $ 1 |
Common Stock, Shares Authorized | 23,000,000 | 23,000,000 |
Common Stock, Shares, Issued | 18,625,458 | 18,620,508 |
Common Stock, Shares, Outstanding | 14,908,517 | 17,102,525 |
Treasury Stock, Shares | 3,716,941 | 1,517,983 |
Condensed Consolidated Income S
Condensed Consolidated Income Statement - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Revenues | ||||
Premiums Earned, Net | $ 75,639 | $ 67,335 | $ 210,507 | $ 195,524 |
Net Investment Income | 4,403 | 4,004 | 12,414 | 12,700 |
Insurance Commissions and Fees | 2,634 | 4,050 | 11,556 | 12,541 |
Other Income | 361 | 2,261 | 2,365 | 8,898 |
Gain (Loss) on Investments, Excluding Other than Temporary Impairments | 715 | 2,367 | 987 | 3,945 |
Revenues | 83,752 | 78,542 | 237,829 | 232,133 |
Other than Temporary Impairment Losses, Investments, Available-for-sale Securities | ||||
Other than Temporary Impairment Losses, Investments, Available-for-sale Securities | 0 | 1,475 | 0 | 1,475 |
Other than Temporary Impairment Losses, Investments, Portion in Other Comprehensive Loss, before Tax, Including Portion Attributable to Noncontrolling Interest, Available-for-sale Securities | 0 | 0 | 0 | 0 |
Net impairment losses recognized in earnings | 0 | 1,475 | 0 | 1,475 |
Operating Expenses | ||||
Policyholder Benefits and Claims Incurred, Net | 33,536 | 38,277 | 103,071 | 109,497 |
Selling, General and Administrative Expense | 42,337 | 32,823 | 115,404 | 97,947 |
Interest Expense, Debt | 0 | 440 | 0 | 1,366 |
Benefits, Losses and Expenses | 75,873 | 71,540 | 218,475 | 208,810 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | 7,879 | 7,002 | 19,354 | 23,323 |
Income taxes (benefits) | 2,666 | 2,636 | (5,175) | 8,566 |
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | 5,213 | 4,366 | 24,529 | 14,757 |
Discontinued Operations and Disposal Groups | ||||
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax | 0 | 0 | 0 | 117,636 |
Discontinued Operation, Tax Effect of Discontinued Operation | 0 | 0 | 0 | 7,724 |
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | 0 | 0 | 0 | 109,912 |
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total | 5,213 | 4,366 | 24,529 | 124,669 |
Net Income (Loss) Attributable to Noncontrolling Interest | (32) | 43 | 4 | 9,900 |
Net Income (Loss) Attributable to Noncontrolling Interest | 16 | 0 | 29 | 0 |
Net Income (Loss) Attributable to Parent, Total | $ 5,229 | $ 4,323 | $ 24,496 | $ 114,769 |
Earnings Per Share, Basic | ||||
Income (Loss) from Continuing Operations, Per Basic Share | $ 0.35 | $ 0.25 | $ 1.53 | $ 0.84 |
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share | 0 | 0 | 0 | 5.84 |
Earnings Per Share, Basic | $ 0.35 | $ 0.25 | $ 1.53 | $ 6.68 |
Weighted Average Number of Shares Outstanding, Basic | 14,965 | 17,120 | 15,999 | 17,189 |
Earnings Per Share, Diluted | ||||
Income (Loss) from Continuing Operations, Per Diluted Share | $ 0.34 | $ 0.25 | $ 1.50 | $ 0.83 |
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share | 0 | 0 | 0 | 5.77 |
Earnings Per Share, Diluted | $ 0.34 | $ 0.25 | $ 1.50 | $ 6.60 |
Weighted Average Number of Shares Outstanding, Diluted | 15,274 | 17,340 | 16,287 | 17,402 |
Condensed Consolidated Statemen
Condensed Consolidated Statement of Comprehensive Income - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Details | ||||
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total | $ 5,213 | $ 4,366 | $ 24,529 | $ 124,669 |
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax | ||||
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax | 250 | (1,173) | 7,219 | 10,734 |
Other Comprehensive Income (Loss), Available-for-sale Securities, Tax | 90 | (418) | 2,599 | 3,830 |
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax | 160 | (755) | 4,620 | 6,904 |
Other Comprehensive Income (Loss), Net of Tax, Total | 160 | (755) | 4,620 | 6,904 |
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | 5,373 | 3,611 | 29,149 | 131,573 |
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest | ||||
Net Income (Loss) Attributable to Noncontrolling Interest | (16) | 43 | 33 | 9,900 |
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest | ||||
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest | 0 | (47) | 0 | 118 |
Other comprehensive (income) loss, net of tax, attributable to noncontrolling interests | 0 | (47) | 0 | 118 |
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest | (16) | (4) | 33 | 10,018 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $ 5,389 | $ 3,615 | $ 29,116 | $ 121,555 |
Condensed Consolidated Stateme6
Condensed Consolidated Statement of Stockholders' Equity - 9 months ended Sep. 30, 2017 - USD ($) $ in Thousands | Total | Common Stock | Additional Paid-in Capital | AOCI Attributable to Parent | Treasury Stock | Retained Earnings | Parent | Noncontrolling Interest |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2016 | $ 439,256 | $ 18,620 | $ 126,468 | $ (6,964) | $ (17,483) | $ 315,918 | $ 436,559 | $ 2,697 |
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest | 24,500 | 24,496 | 24,496 | 4 | ||||
Other Comprehensive Income (Loss), Net of Tax, Total | 4,620 | 4,620 | 4,620 | 0 | ||||
Treasury Stock, Value, Acquired, Cost Method | (44,442) | (44,442) | (44,442) | 0 | ||||
Common stock dividend ($.06 per share) | (902) | (902) | (902) | |||||
Distributions to noncontrolling interests | (25) | (25) | ||||||
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition | (115) | 5 | (333) | 213 | (115) | 0 | ||
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Sep. 30, 2017 | $ 422,892 | $ 18,625 | $ 126,135 | $ (2,344) | $ (61,712) | $ 339,512 | $ 420,216 | $ 2,676 |
Condensed Consolidated Stateme7
Condensed Consolidated Statement of Stockholders' Equity - Parenthetical | 9 Months Ended |
Sep. 30, 2017$ / shares | |
Details | |
Common Stock, Dividends, Per Share, Declared | $ 0.06 |
Condensed Consolidated Stateme8
Condensed Consolidated Statement of Cash Flows - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2017 | Sep. 30, 2016 | |
CASH FLOWS PROVIDED BY (USED BY) OPERATING ACTIVITIES: | ||
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total | $ 24,529 | $ 124,669 |
Net Cash Provided by (Used in) Operating Activities | 16,030 | (16,753) |
Adjustments to reconcile net income to net change in cash from | ||
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax | 0 | 109,447 |
Deferred Policy Acquisition Costs, Amortization Expense | 269 | 245 |
Gain (Loss) on Investments, Excluding Other than Temporary Impairments | 987 | 3,945 |
Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net | 0 | 1,475 |
Income (Loss) from Equity Method Investments | 1,412 | (7) |
Depreciation, Depletion and Amortization, Nonproduction | 1,379 | 1,482 |
Deferred Income Tax Expense (Benefit) | 1,853 | 2,565 |
Other Noncash Income (Expense) | (4,852) | (6,683) |
Increase (Decrease) in Operating Capital | ||
Proceeds from (Payments for) Trading Securities, Short-term | 0 | 3,180 |
Increase (Decrease) in Insurance Liabilities | (83,750) | (41,713) |
Increase (Decrease) in Premiums Receivable | (10,218) | (11,621) |
Increase (Decrease) in Reinsurance Recoverable | (57,094) | (4,227) |
Change in premium and claim funds | (4,287) | 4,835 |
Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable | (8,604) | (6,550) |
Increase (Decrease) in Other Operating Assets and Liabilities, Net | (6,302) | 6,417 |
Net Cash Provided by (Used in) Investing Activities | ||
Payments for (Proceeds from) Short-term Investments | (6,849) | 8,104 |
Proceeds from (Payments for) Securities Purchased under Agreements to Resell | 8,365 | 17,003 |
Proceeds from Sale of Available-for-sale Securities, Equity | 0 | 2,429 |
Proceeds from Sale of Available-for-sale Securities, Debt | 158,062 | 335,562 |
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities | 16,841 | 35,505 |
Payments to Acquire Available-for-sale Securities, Debt | 145,444 | 406,348 |
Proceeds from Divestiture of Businesses, Net of Cash Divested | 0 | 137,115 |
Payments to Acquire Businesses, Net of Cash Acquired | 12,323 | 0 |
Proceeds from Equity Method Investment, Distribution, Return of Capital | 5,246 | 0 |
Proceeds from Sale and Maturity of Other Investments | 0 | 2,064 |
Payments to Acquire Other Investments | 602 | 3,371 |
Other investing activities | 565 | 3,433 |
Net Cash Provided by (Used in) Investing Activities | 36,429 | 108,422 |
Net Cash Provided by (Used in) Financing Activities | ||
Payments for repurchases of common stock | 44,290 | 3,522 |
Cash paid in acquisitions of noncontrolling interests | 0 | 18,141 |
Net Change Annuities and Investment Certificates | (1,359) | (1,447) |
Repayments of debt | 0 | 4,789 |
Dividends paid | 1,927 | 1,588 |
Proceeds from (Payments for) Other Financing Activities | (328) | (474) |
Net Cash Provided by (Used in) Financing Activities | (47,904) | (29,961) |
Cash and Cash Equivalents, Period Increase (Decrease) | 4,555 | 61,708 |
Cash and Cash Equivalents, at Carrying Value, Beginning Balance | 22,010 | 17,500 |
Cash and Cash Equivalents, at Carrying Value, Ending Balance | $ 26,565 | $ 79,208 |
Organization, Consolidation, Ba
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] | 9 Months Ended |
Sep. 30, 2017 | |
Notes | |
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies | Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies (A) Business and Organization (B) Consolidation (C) Basis of Presentation The unaudited Condensed Consolidated Financial Statements have been prepared in conformity with U.S. generally accepted accounting principles ("GAAP") for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X and, therefore, do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements include the accounts of IHC and its consolidated subsidiaries. All significant intercompany transactions have been eliminated in consolidation. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect: (i) the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements; and (ii) the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. IHC’s annual report on Form 10-K as filed with the Securities and Exchange Commission should be read in conjunction with the accompanying unaudited Condensed Consolidated Financial Statements. In the opinion of management, all adjustments (consisting only of normal recurring accruals) that are necessary for a fair presentation of the consolidated financial position and results of operations for the interim periods have been included. The condensed consolidated results of operations for the three months and nine months ended September 30, 2017 are not necessarily indicative of the results to be anticipated for the entire year. assessment of equity securities without readily determinable fair values and requires changes in disclosure requirements. For public entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption is permitted in certain circumstances. The amendments in this Update should be applied by means of a cumulative-effect adjustment to the balance sheet as of the beginning of the fiscal year of adoption. The amendments related to equity securities without readily determinable fair values (including disclosure requirements) should be applied prospectively to equity investments that exist as of the date of adoption of the guidance. The adoption of this guidance is not expected to have a material effect on the Company’s Consolidated Balance Sheet or IHC’s stockholders’ equity. In May 2014, the FASB issued revenue recognition guidance for entities that either enter into contracts with customers to transfer goods or services or enter into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards such as insurance contracts or lease contracts. The amendment provides specific steps that an entity should apply in order to achieve its main objective which is recognizing revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In 2016, additional guidance and technical corrections were issued to clarify certain aspects of the implementation guidance and to clarify the identification of performance obligations. In August 2015, the effective date of this guidance has been deferred. For public entities, this guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period, and requires one of two specified retrospective methods of application. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. The Company anticipates that any impact will only relate to contracts with customers outside the scope of Accounting Standards Codification Topic 944, Financial Services - Insurance. Our administrative and other service contracts that will be subject to the amendments in this Update are recorded in the Fee Income line item of the Condensed Consolidated Statement of Income and represent approximately 5% of our consolidated revenues for the nine months ended September 30, 2017. The guidance will be applied retrospectively with a cumulative effect adjustment on the date of initial application. Management is still in the process of evaluating the impact that the adoption of this guidance will have on the Company’s consolidated financial statements and does not anticipate any significant changes in internal controls over financial reporting as a result of its implementation. |
Earnings Per Share _Text Block_
Earnings Per Share [Text Block] | 9 Months Ended |
Sep. 30, 2017 | |
Notes | |
Earnings Per Share | Note 2. Income Per Common Share Diluted income per share was computed using the treasury stock method and includes incremental common shares, primarily from the dilutive effect of share-based payment awards, amounting to 309,000 and 288,000 shares for the three months and nine months ended September 30, 2017, respectively, and 220,000 and 213,000 shares for the three months and nine months ended September 30, 2016, respectively. The following is a reconciliation of income available to common shareholders used to calculate income per share for the periods indicated (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Income from continuing operations, net of tax $ 5,213 $ 4,366 $ 24,529 $ 14,757 Less: (Income) loss from continuing operations attributable to noncontrolling interests 16 (43) (33) (348) Income from continuing operations attributable to IHC common shareholders $ 5,229 $ 4,323 $ 24,496 $ 14,409 Income from discontinued operations, net of tax $ - $ - $ - $ 109,912 Less: Income from discontinued operations attributable to noncontrolling interests - - - (9,552) Income from discontinued operations attributable to IHC common shareholders $ - $ - $ - $ 100,360 Net income attributable to IHC $ 5,229 $ 4,323 $ 24,496 $ 114,769 |
Disposal Groups, Including Disc
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] | 9 Months Ended |
Sep. 30, 2017 | |
Notes | |
Disposal Groups, Including Discontinued Operations, Disclosure | Note 3. Discontinued Operations On March 31, 2016, IHC and a subsidiary of AMIC, sold the stock of IHC Risk Solutions, LLC (“Risk Solutions”) to Swiss Re Corporate Solutions, a division of Swiss Re (“Swiss Re”). In addition, under the purchase and sale agreement, all of the in-force stop-loss business of Standard Security Life and Independence American produced by Risk Solutions is co-insured by Westport Insurance Corporation (“Westport”), Swiss Re’s largest US carrier, as of January 1, 2016. The aggregate purchase price, prior to closing adjustments, was $152,500,000 in cash. Approximately 89% of the purchase price was allocated to AMIC, with the balance being paid to Standard Security Life and other IHC subsidiaries. The Company recorded a gain of $99,934,000, net of taxes and amounts attributable to noncontrolling interests, as a result of the transaction. The aforementioned transaction, which includes the sale of Risk Solutions and the corresponding coinsurance agreement, is collectively referred to as the “Risk Solutions Sale and Coinsurance Transaction”. IHC’s block of Medical Stop-Loss business is in run-off. The sale of Risk Solutions and exit from the medical stop-loss business represented a strategic shift that has had a major effect on the Company’s operations and financial results. The disposal transaction qualified for reporting as a discontinued operation in the first quarter of 2016 as a result of the Board of Directors commitment to a plan for its disposal in January 2016. Aside from reinsurance and marketing of Westport small group stop-loss, there has been no further involvement with the discontinued operation. The following is a reconciliation of the major line items constituting the pretax profit of discontinued operations included in the Condensed Consolidated Statement of Income for the periods indicated (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2016 2016 Revenue $ - $ 6,406 Selling, general and administrative expenses - 5,689 Pretax profit of discontinued operations - 717 Gain on disposal of discontinued operations, pretax - 116,919 Income from discontinued operations, before income taxes - 117,636 Income taxes (benefits) on discontinued operations - 7,724 Income from discontinued operations $ - $ 109,912 Liabilities attributable to discontinued operations at September 30, 2017 and December 31, 2016 consist of $0 and $68,000, respectively, of accounts payable and accrued liabilities. In connection with the Risk Solutions Sale and Coinsurance Transaction in March 2016, AMIC utilized a significant amount of its Federal NOL carryforwards and made a corresponding adjustment to its valuation allowance. On a consolidated basis, the Company recorded income taxes on discontinued operations of $7,724,000 for the nine months ended September 30, 2016, consisting of $5,777,000 of state taxes and $1,947,000 of Federal taxes, net of a $38,419,000 decrease in AMIC’s valuation allowance. |
Investments in Debt and Marketa
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] | 9 Months Ended |
Sep. 30, 2017 | |
Notes | |
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure | Note 4. Investment Securities The cost (amortized cost with respect to certain fixed maturities), gross unrealized gains, gross unrealized losses and fair value of investment securities are as follows for the periods indicated (in thousands): September 30, 2017 GROSS GROSS AMORTIZED UNREALIZED UNREALIZED FAIR COST GAINS LOSSES VALUE FIXED MATURITIES AVAILABLE-FOR-SALE: Corporate securities $ 159,753 $ 894 $ (2,471) $ 158,176 CMOs - residential (1) 7,011 - (106) 6,905 U.S. Government obligations 44,077 57 (257) 43,877 Agency MBS - residential (2) 16 - - 16 GSEs (3) 9,992 1 (211) 9,782 States and political subdivisions 194,724 1,143 (2,828) 193,039 Foreign government obligations 4,276 22 (85) 4,213 Redeemable preferred stocks 10,008 116 (132) 9,992 Total fixed maturities $ 429,857 $ 2,233 $ (6,090) $ 426,000 EQUITY SECURITIES AVAILABLE-FOR-SALE: Common stocks $ 1,612 $ 191 $ (18) $ 1,785 Nonredeemable preferred stocks 3,587 88 - 3,675 Total equity securities $ 5,199 $ 279 $ (18) $ 5,460 December 31, 2016 GROSS GROSS AMORTIZED UNREALIZED UNREALIZED FAIR COST GAINS LOSSES VALUE FIXED MATURITIES AVAILABLE-FOR-SALE: Corporate securities $ 192,976 $ 209 $ (5,490) $ 187,695 CMOs - residential (1) 6,021 8 (116) 5,913 U.S. Government obligations 43,417 133 (441) 43,109 Agency MBS - residential (2) 22 1 - 23 GSEs (3) 10,301 1 (422) 9,880 States and political subdivisions 191,146 780 (5,115) 186,811 Foreign government obligations 5,098 13 (157) 4,954 Redeemable preferred stocks 11,454 96 (448) 11,102 Total fixed maturities $ 460,435 $ 1,241 $ (12,189) $ 449,487 EQUITY SECURITIES AVAILABLE-FOR-SALE: Common stocks $ 1,612 $ 178 $ - $ 1,790 Nonredeemable preferred stocks 3,588 30 (75) 3,543 Total equity securities $ 5,200 $ 208 $ (75) $ 5,333 (1) (2) (3) The amortized cost and fair value of fixed maturities available-for-sale at September 30, 2017, by contractual maturity, are shown below (in thousands). Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. AMORTIZED FAIR COST VALUE Due in one year or less $ 29,686 $ 29,631 Due after one year through five years 113,190 112,572 Due after five years through ten years 145,877 145,322 Due after ten years 124,085 121,772 Fixed maturities with no single maturity date 17,019 16,703 $ 429,857 $ 426,000 The following tables summarize, for all available-for-sale securities in an unrealized loss position, the aggregate fair value and gross unrealized loss by length of time those securities that have continuously been in an unrealized loss position for the periods indicated (in thousands): September 30, 2017 Less than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Corporate securities $ 84,636 $ 1,087 $ 25,563 $ 1,384 $ 110,199 $ 2,471 CMOs - residential 4,730 101 2,105 5 6,835 106 U.S. Government obligations 18,021 80 12,619 177 30,640 257 GSEs 3,286 65 6,480 146 9,766 211 States and political subdivisions 88,326 1,413 35,771 1,415 124,097 2,828 Foreign government obligations - - 3,006 85 3,006 85 Redeemable preferred stocks - - 3,631 132 3,631 132 Total fixed maturities 198,999 2,746 89,175 3,344 288,174 6,090 Common stocks 485 18 - - 485 18 Total equity securities 485 18 - - 485 18 Total temporarily impaired securities $ 199,484 $ 2,764 $ 89,175 $ 3,344 $ 288,659 $ 6,108 Number of securities in an unrealized loss position 107 44 151 December 31, 2016 Less than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Corporate securities $ 145,205 $ 3,818 $ 19,841 $ 1,672 $ 165,046 $ 5,490 CMO’s - residential 5,038 116 - - 5,038 116 U.S. Government obligations 28,406 441 - - 28,406 441 GSEs 3,640 166 6,220 256 9,860 422 States and political subdivisions 144,357 4,561 18,132 554 162,489 5,115 Foreign government obligations 3,738 157 - - 3,738 157 Redeemable preferred stocks - - 3,315 448 3,315 448 Total fixed maturities 330,384 9,259 47,508 2,930 377,892 12,189 Nonredeemable preferred stocks 826 25 1,277 50 2,103 75 Total equity securities 826 25 1,277 50 2,103 75 Total temporarily impaired securities $ 331,210 $ 9,284 $ 48,785 $ 2,980 $ 379,995 $ 12,264 Number of securities in an unrealized loss position 156 23 179 Substantially all of the unrealized losses on fixed maturities available-for-sale at September 30, 2017 and December 31, 2016 relate to investment grade securities and are attributable to changes in market interest rates. Because the Company does not intend to sell, nor is it more likely than not that the Company will have to sell such investments before recovery of their amortized cost bases, which may be maturity, the Company does not consider these investments to be other-than-temporarily impaired at September 30, 2017 Net realized investment gains are as follows for periods indicated (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Available-for-sale securities: Fixed maturities $ 719 $ 2,226 $ 1,062 $ 3,847 Common stocks - 220 - 220 Total available-for-sale securities 719 2,446 1,062 4,067 Trading securities - - - - Total realized gains 719 2,446 1,062 4,067 Unrealized gains (losses) on trading securities: Change in unrealized gains (losses) on trading securities (4) (80) (76) (124) Total unrealized gains (losses) on trading securities (4) (80) (76) (124) Gains (losses) on other investments - 1 1 2 Net realized investment gains $ 715 $ 2,367 $ 987 $ 3,945 and $339,171,000, respectively, and the Company realized gross gains of $2,668,000 and $4,521,000, respectively, and gross losses of $94,000 and $275,000, respectively, on those sales. Other-Than-Temporary Impairment Evaluations We recognize other-than-temporary impairment losses in earnings in the period that we determine: 1) we intend to sell the security; 2) it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis; or 3) the security has a credit loss. Any non-credit portion of the other-than-temporary impairment loss is recognized in other comprehensive income (loss). See Note 1G(iv) to the Consolidated Financial Statements in the 2016 Annual Report for further discussion of the factors considered by management in its regular review to identify and recognize other-than-temporary impairments on available-for-sale securities. The Company did not recognize any other-than-temporary impairments on available-for-sale securities in the first nine months of 2017. In the three months and nine months ended September 30, 2016, the Company recognized an other-than-temporary impairment loss of $1,475,000 on certain fixed maturities available-for-sale due to credit losses. The Company determined it was more likely than not that the securities would be sold before the recovery of their amortized cost basis. Credit losses were recognized on certain fixed maturities for which each security also had an impairment loss recognized in other comprehensive income (loss). The rollforward of these credit losses were as follows for the periods indicated (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Balance at beginning of year $ - $ - $ - $ 473 Securities sold - - - (473) Balance at end of period $ - $ - $ - $ - |
Fair Value Disclosures _Text Bl
Fair Value Disclosures [Text Block] | 9 Months Ended |
Sep. 30, 2017 | |
Notes | |
Fair Value Disclosures | Available-for-sale securities included in Level 1 are equities with quoted market prices. Level 2 is primarily comprised of our portfolio of government securities, agency mortgage-backed securities, corporate fixed income securities, foreign government obligations, collateralized mortgage obligations, municipals and GSEs that were priced with observable market inputs. Level 3 securities consist of municipal tax credit strips. The valuation method used to determine the fair value of municipal tax credit strips is the present value of the remaining future tax credits (at the original issue discount rate) as presented in the redemption tables in the Municipal Prospectuses. This original issue discount is accreted into income on a constant yield basis over the term of the debt instrument. Further we retain independent pricing vendors to assist in valuing certain instruments. Trading securities: The following tables present our financial assets measured at fair value on a recurring basis for the periods indicated (in thousands): September 30, 2017 Level 1 Level 2 Level 3 Total FINANCIAL ASSETS: Fixed maturities available-for-sale: Corporate securities $ - $ 158,176 $ - $ 158,176 CMOs - residential - 6,905 - 6,905 US Government obligations - 43,877 - 43,877 Agency MBS - residential - 16 - 16 GSEs - 9,782 - 9,782 States and political subdivisions - 191,124 1,917 193,041 Foreign government obligations - 4,213 - 4,213 Redeemable preferred stocks 9,990 - - 9,990 Total fixed maturities 9,990 414,093 1,917 426,000 Equity securities available-for-sale: Common stocks 1,785 - - 1,785 Nonredeemable preferred stocks 3,675 - - 3,675 Total equity securities 5,460 - - 5,460 Trading securities - equities 516 - - 516 Total trading securities 516 - - 516 Total Financial Assets $ 15,966 $ 414,093 $ 1,917 $ 431,976 December 31, 2016 Level 1 Level 2 Level 3 Total FINANCIAL ASSETS: Fixed maturities available-for-sale: Corporate securities $ - $ 187,695 $ - $ 187,695 CMOs - residential - 5,913 - 5,913 US Government obligations - 43,109 - 43,109 Agency MBS - residential - 23 - 23 GSEs - 9,880 - 9,880 States and political subdivisions - 184,778 2,033 186,811 Foreign government obligations - 4,954 - 4,954 Redeemable preferred stocks 11,102 - - 11,102 Total fixed maturities 11,102 436,352 2,033 449,487 Equity securities available-for-sale: Common stocks 1,790 - - 1,790 Nonredeemable preferred stocks 3,543 - - 3,543 Total equity securities 5,333 - - 5,333 Trading securities - equities 592 - - 592 Total trading securities 592 - - 592 Total Financial Assets $ 17,027 $ 436,352 $ 2,033 $ 455,412 It is the Company’s policy to recognize transfers of assets and liabilities between levels of the fair value hierarchy at the end of a reporting period. The Company does not transfer out of Level 3 and into Level 2 until such time as observable inputs become available and reliable or the range of available independent prices narrow. The Company did not transfer any securities between Level 1, Level 2 or Level 3 in either 2017 or 2016. The following table presents the changes in fair value of our Level 3 financial assets for the periods indicated (in thousands): Three Months Ended September 30, 2017 2016 States and Total States and Total Political Level 3 Political Level 3 Subdivisions Assets Subdivisions Assets Beginning balance $ 1,956 $ 1,956 $ 2,107 $ 2,107 Increases (decreases) recognized in earnings: Net realized investment gains - - - - Gains (losses) included in other comprehensive income (loss): Net unrealized gains (losses) (8) (8) (10) (10) Repayments and amortization of fixed maturities (31) (31) (27) (27) Sales - - - - Balance at end of period $ 1,917 $ 1,917 $ 2,070 $ 2,070 Nine Months Ended September 30, 2017 2016 States and Total States and Total Political Level 3 CMOs Political Level 3 Subdivisions Assets Commercial Subdivisions Assets Beginning balance $ 2,033 $ 2,033 $ 1,195 $ 2,179 $ 3,374 Gains (losses) included in earnings: Net realized investment gains - - 141 - 141 Gains (losses) included in other comprehensive income (loss): Net unrealized gains (losses) (26) (26) (296) (31) (327) Repayments and amortization of fixed maturities (90) (90) (74) (78) (152) Sales - - (966) - (966) Balance at end of period $ 1,917 $ 1,917 $ - $ 2,070 $ 2,070 During 2016, the Company had contingent liabilities classified in Level 3 of the fair value hierarchy. These liabilities were paid out by December 31, 2016; there were no comparable amounts in 2017. The following table presents the changes in fair value of our Level 3 financial liabilities for the periods indicated (in thousands): Three Months Ended Nine Months Ended September 30, 2016 September 30, 2016 Total Total Contingent Level 3 Contingent Level 3 Liabilities Liabilities Liabilities Liabilities Beginning balance $ 1,445 $ 1,445 $ 1,650 $ 1,650 Gains (losses) included in earnings: Net investment income (204) (204) (947) (947) Other income (185) (185) 353 353 Payment of contingent liability (700) (700) (700) (700) Balance at end of period $ 356 $ 356 $ 356 $ 356 The following table provides carrying values, fair values and classification in the fair value hierarchy of the Company’s financial instruments, for the periods indicated, that are not carried at fair value but are subject to fair value disclosure requirements, for the periods indicated (in thousands): September 30, 2017 December 31, 2016 Level 1 Level 2 Level 1 Level 2 Fair Fair Carrying Fair Fair Carrying Value Value Value Value Value Value FINANCIAL ASSETS: Short-term investments $ 50 $ - $ 50 $ 6,912 $ - $ 6,912 FINANCIAL LIABILITIES: Funds on deposit $ - $ 143,911 $ 143,637 $ - $ 146,098 $ 145,749 The following methods and assumptions were used to estimate the fair value of the financial instruments that are not carried at fair value in the Condensed Consolidated Financial Statements: Short-term Investments Investments with original maturities of 91 days to one year are considered short-term investments and are carried at cost, which approximates fair value. Funds on Deposit The Company has two types of funds on deposit. The first type is credited with a current market interest rate, resulting in a fair value which approximates the carrying amount. The second type carries fixed interest rates which are higher than current market interest rates. The fair value of these deposits was estimated by discounting the payments using current market interest rates. The Company's universal life policies are also credited with current market interest rates, resulting in a fair value which approximates the carrying amount. Both types of funds on deposit are included in Level 2 of the fair value hierarchy. |
Variable Interest Entity Disclo
Variable Interest Entity Disclosure [Text Block] | 9 Months Ended |
Sep. 30, 2017 | |
Notes | |
Variable Interest Entity Disclosure | Note 6. Variable Interest Entities The Company will periodically reassess whether we are the primary beneficiary in any of these investments. The reassessment process will consider whether we have acquired the power to direct the most significant activities of the VIEs through changes in governing documents or other circumstances. Our maximum loss exposure is limited to our combined $4,141,000 carrying value in these equity investments that are included in other investments in the Condensed Consolidated Balance Sheet as of September 30, 2017. |
Business Combination Disclosure
Business Combination Disclosure [Text Block] | 9 Months Ended |
Sep. 30, 2017 | |
Notes | |
Business Combination Disclosure | Note 7. Acquisition of PetPartners, Inc. On March 24, 2017 (the "Acquisition Date"), the Company acquired 85% of the stock of PetPartners, Inc. (“PetPartners”), a pet insurance marketing and administration company, for a purchase price of $12,713,000, subject to certain post-closing adjustments. The Company acquired PetPartners for the purpose of owning additional distribution and administration sources for its pet insurance. Any time after March 24, 2019, shares owned by the noncontrolling interest are putable to the Company at fair value and are therefore presented on the balance sheet as a redeemable noncontrolling interest. Upon the acquisition, the Company consolidated the assets and liabilities of PetPartners. The following table presents the identifiable assets acquired and liabilities assumed in the acquisition of PetPartners on the Acquisition Date based on their respective fair values (in thousands): Cash $ 390 Intangible assets 5,880 Other assets 567 Total identifiable assets 6,837 Other liabilities 174 Deferred tax liability 1,069 Total liabilities 1,243 Net identifiable assets acquired $ 5,594 Redeemable noncontrolling interest $ 2,005 expects to finalize the preliminary estimates of the fair value of the intangible assets and deferred taxes by the end of this year. Acquisition-related costs, primarily legal and consulting fees, were expensed and are included in selling, general and administrative expenses in the Condensed Consolidated Statement of Income. For the period from the Acquisition Date to September 30, 2017, the Company’s Condensed Consolidated Statement of Income includes revenues of $1,416,000 and $2,869,000, respectively, for the three months and nine months ended September 30, 2017, and net income of $112,000 and $199,000, respectively, for the three months and nine months ended September 30, 2017 from PetPartners. Pro forma adjustments to present the Company’s consolidated revenues and net income as if the acquisition date was January 1, 2016 are not material and accordingly are omitted. |
Goodwill and Intangible Assets
Goodwill and Intangible Assets Disclosure [Text Block] | 9 Months Ended |
Sep. 30, 2017 | |
Notes | |
Goodwill and Intangible Assets Disclosure | Note 8. Goodwill and Other Intangible Assets The carrying amount of goodwill was $50,697,000 and $41,573,000 at September 30, 2017 and December 31, 2016, respectively. Goodwill is reviewed for impairment annually at December 31, and evaluated for triggering events that may indicate a potential impairment quarterly. As of September 30, 2017, no impairment indicators were identified. The Company has net other intangible assets of $15,062,000 and $10,122,000 at September 30, 2017 and December 31, 2016, respectively, which are included in other assets in the Condensed Consolidated Balance Sheets. These intangible assets consist of: (i) finite-lived intangible assets, principally the fair value of acquired agent and broker relationships, which are subject to amortization; and (ii) indefinite-lived intangible assets which consist of the estimated fair value of insurance licenses that are not subject to amortization. The gross carrying amounts of these other intangible assets are as follows for the periods indicated (in thousands): September 30, 2017 December 31, 2016 Gross Gross Carrying Accumulated Carrying Accumulated Amount Amortization Amount Amortization Finite-lived Intangible Assets: Agent and broker relationships $ 17,253 $ 11,797 $ 13,052 $ 11,882 Domain 1,000 100 1,000 25 Software systems 780 51 - - Total finite-lived $ 19,033 $ 11,948 $ 14,052 $ 11,907 September 30, December 31, 2017 2016 Indefinite-lived Intangible Assets: Insurance licenses $ 7,977 $ 7,977 Total indefinite-lived $ 7,977 $ 7,977 ended September 30, 2016, respectively. |
Income Tax Disclosure _Text Blo
Income Tax Disclosure [Text Block] | 9 Months Ended |
Sep. 30, 2017 | |
Notes | |
Income Tax Disclosure | Note 9. Income Taxes The provisions for income taxes shown in the Condensed Consolidated Statements of Income were computed based on the Company's actual results, which approximate the effective tax rate expected to be applicable for the balance of the current fiscal year in accordance with consolidated life/non-life group income tax regulations. Such regulations adopt a subgroup method in determining consolidated taxable income, whereby taxable income is determined separately for the life insurance company group and the non-life insurance company group. As a result of the winding down of operations and dissolution of IHC Administrative Services, Inc. (“IHC AS”), a subsidiary of IHC, in the quarter ended June 30, 2017, the Company recognized an estimated $11,589,000 income tax benefit on a worthless stock deduction of $33,110,000 representing the Company’s tax basis related to its unrecovered investment in IHC AS. Management believes that it is more likely than not that the Company will realize the income tax benefit of this worthless stock deduction. Excluding this tax benefit, the differences between the Federal statutory income tax rate of 35% and the Company’s effective income tax rate resulted principally from the dividends received deduction and tax exempt interest income, state and local income taxes, and health insurer specific tax provisions. |
Liability for Future Policy Ben
Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block] | 9 Months Ended |
Sep. 30, 2017 | |
Notes | |
Liability for Future Policy Benefits and Unpaid Claims Disclosure | Since unpaid loss and loss adjustment expenses are estimates, actual losses incurred may be more or less than the Company’s previously developed estimates and is referred to as either unfavorable or favorable development, respectively. The overall net favorable development of $9,236,000 in 2017 related to prior years consists of favorable developments of $2,420,000 in the Medical Stop-Loss reserves, $5,406,000 in the group disability reserves and $2,714,000 in the other individual life, annuities and other reserves, partially offset by an unfavorable development of $1,304,000 in Specialty Health reserves. The overall net favorable development of $7,048,000 in 2016 related to prior years primarily consists of favorable developments of $2,916,000 in the group disability reserves, $494,000 in Medical Stop-Loss reserves, and $3,769,000 in Specialty health reserves. Included in the preceding rollforward of the Company’s liability for policy benefits and claims are the policy benefits and claims activity associated with the Company’s health insurance lines. These are embedded within the Specialty Health segment. The table below summarizes the components of the change in the liability for policy benefits and claims that are specific to health insurance claims for the periods indicated (in thousands). Specialty Health Segment Health Insurance Claims Nine Months Ended September 30, 2017 2016 Balance at beginning of year $ 27,183 $ 23,425 Less: reinsurance recoverable 1,179 1,362 Net balance at beginning of year 26,004 22,063 Amount incurred, related to: Current year 40,836 34,598 Prior years 1,144 (6,845) Total incurred 41,980 27,753 Amount paid, related to: Current year 13,528 9,541 Prior years 23,797 13,105 Total paid 37,325 22,646 Net balance at end of period 30,659 27,170 Plus: reinsurance recoverable 814 848 Balance at end of period $ 31,473 $ 28,018 The liability for the IBNR plus expected development on reported claims associated with the Company’s health insurance claims was $30,659,000 at September 30, 2017. |
Stockholders' Equity Note Discl
Stockholders' Equity Note Disclosure [Text Block] | 9 Months Ended |
Sep. 30, 2017 | |
Notes | |
Stockholders' Equity Note Disclosure | Note 11. Stockholders’ Equity Treasury Stock Accumulated Other Comprehensive Income (Loss) Other comprehensive income (loss) includes the after-tax net unrealized gains and losses on investment securities available-for-sale, including the subsequent increases and decreases in fair value of available-for-sale securities previously impaired and the non-credit related component of other-than-temporary impairments of fixed maturities. Changes in the balances of accumulated other comprehensive income, shown net of taxes, for the periods indicated were as follows (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Beginning balance $ (2,504) $ 4,054 $ (6,964) $ (3,440) Other comprehensive income (loss) before reclassifications 627 (182) 5,305 8,522 Amounts reclassified from accumulated OCI (467) (573) (685) (1,618) Net other comprehensive income 160 (755) 4,620 6,904 Less: Other comprehensive income attributable to noncontrolling interests - 47 - (118) Acquired from noncontrolling interests - 102 - 102 Ending balance $ (2,344) $ 3,448 $ (2,344) $ 3,448 Presented below are the amounts reclassified out of accumulated other comprehensive income (loss) and recognized in earnings for each of the periods indicated (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Unrealized gains (losses) on available-for-sale securities reclassified during the period to the following income statement line items: Net realized investment gains $ 719 $ 2,446 $ 1,062 $ 4,067 Net impairment losses recognized in earnings - (1,475) - (1,475) Income before income tax 719 971 1,062 2,592 Tax effect 252 398 377 974 Net income $ 467 $ 573 $ 685 $ 1,618 |
Compensation and Employee Benef
Compensation and Employee Benefit Plans [Text Block] | 9 Months Ended |
Sep. 30, 2017 | |
Notes | |
Compensation and Employee Benefit Plans | Note 12. Share-Based Compensation IHC has a share-based compensation plan. AMIC had a plan, which has now been terminated. The following is a summary of the activity pertaining to each of these plans. A) IHC Share-Based Compensation Plans Under the terms of IHC’s share-based compensation plans: (i) the exercise price of an option may not be less than the fair market value of an IHC share on the grant date and the terms of an option may not exceed 10 years from the grant date; and (ii) the exercise price of a SAR may not be less than the fair market value of an IHC share on the grant date and SAR terms may not exceed 10 years from the date of grant. The fair value of an option award is estimated on the date of grant using the Black-Scholes option valuation model. In general, the vesting period for an option grant is 3years. Restricted share units are valued at the quoted market price of the shares at the date of grant and generally vest over 3years. Compensation costs for options and restricted share units are recognized over the stated vesting periods on a straight-line basis. The fair value of a SAR is calculated using the Black-Scholes valuation model at the grant date and each subsequent reporting period until settlement. Compensation cost is based on the proportionate amount of the requisite service that has been rendered to date. Once fully vested, changes in the fair value of a SAR continue to be recognized as compensation expense in the period of the change until settlement. The Company accounts for forfeitures of share-based compensation awards in the period that they occur. At September 30, 2017, there were 1,099,100 shares available for future stock-based compensation grants under IHC’s stock incentive plan. The following table summarizes share-based compensation expense, which is included in selling, general and administrative expenses on the Condensed Consolidated Statements of Income, applicable to the IHC plans, by award type for each of the periods indicated (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 IHC’s Share-based Compensation Plan: Stock options $ 36 $ - $ 106 $ 170 Restricted stock units 23 16 81 60 SARs 305 (57) 359 410 Share-based compensation expense, pre-tax 364 (41) 546 640 Tax benefits 145 16 218 255 Share-based compensation expense, net $ 219 $ (25) $ 328 $ 385 Stock Options The IHC’s stock option activity during 2017 was as follows: Shares Weighted- Average Under Option Exercise Price December 31, 2016 697,180 $ 11.75 Granted 34,000 22.20 Exercised (38,800) 9.09 September 30, 2017 692,380 $ 12.41 2017 Weighted-average risk-free interest rate 1.71% Expected annual dividend rate per share 0.79% Expected volatility factor of the Company's common stock 37.57% Weighted-average expected term of options 4.5 years in IHC shares. As part of the net-share settlements in 2017, cash outflows to satisfy employees’ income tax withholding obligations amounted to $303,000. Stock options exercised in 2017 had an aggregate intrinsic value of $621,000 and IHC realized $180,000 of tax benefits. In 2016, option agreements affecting 13 employees were modified to extend the expirations of their terms from 2017 to 2019 and, as a result, the Company recorded incremental compensation costs of $170,000. In 2016, IHC received $84,000 in cash from the exercise of stock options with an aggregate intrinsic value of $67,000 and realized $15,000 of tax benefits. The following table summarizes information regarding IHC’s outstanding and exercisable options: September 30, 2017 Outstanding Exercisable Number of options 692,380 501,380 Weighted average exercise price per share $ 12.41 $ 9.39 Aggregate intrinsic value for all options (in thousands) $ 8,889 $ 7,953 Weighted average contractual term remaining 1.9 years 1.0 years At September 30, 2017, the total unrecognized compensation cost related to IHC’s non-vested stock options was $537,000 and it is expected to be recognized as compensation expense over a weighted average period of 2.3 years. Restricted Stock The following table summarizes restricted stock activity for the nine months ended September 30, 2017: No. of Weighted-Average Non-vested Grant-Date Shares Fair Value December 31, 2016 17,325 $ 16.20 Vested (4,950) 12.53 September 30, 2017 12,375 $ 17.68 The total fair value of restricted stock units that vested during the first nine months of 2017 and 2016 was $94,000 and $120,000, respectively. IHC granted no restricted stock awards during the nine months ended September 30, 2017 and 2016. At September 30, 2017, the total unrecognized compensation cost related to non-vested restricted stock unit awards was $153,000 which is expected to be recognized as compensation expense over a weighted average period of 1.8 years. SARs IHC had 30,800 and 71,500 of SAR awards outstanding at September 30, 2017 and December 31, 2016, respectively. In the first nine months of 2017, 40,700 SARs were exercised with an aggregate intrinsic value of $676,000. Included in Other Liabilities in the Company’s Condensed Consolidated Balance Sheets at September 30, 2017 and December 31, 2016 are liabilities of $559,000 and $876,000, respectively, pertaining to SARs. AMIC received $262,000 in cash from the exercise of stock options with an intrinsic value of $212,000. |
Cash Flow, Supplemental Disclos
Cash Flow, Supplemental Disclosures [Text Block] | 9 Months Ended |
Sep. 30, 2017 | |
Notes | |
Cash Flow, Supplemental Disclosures | Note 13. Supplemental Disclosures of Cash Flow Information Net cash payments for income taxes were $292,000 and $11,312,000 during the nine months ended September 30, 2017 and 2016. Cash payments for interest were $0 and $1,422,000 during the nine months ended September 30, 2017 and 2016, respectively. |
Commitments and Contingencies D
Commitments and Contingencies Disclosure [Text Block] | 9 Months Ended |
Sep. 30, 2017 | |
Notes | |
Commitments and Contingencies Disclosure | Note 14. Contingencies A third party administrator with whom we formerly did business (“Plaintiff”) filed a Complaint dated May 17, 2017 in the United States District Court, Northern District of Texas, Dallas Division, naming IHC, Madison National Life, Standard Security Life, and IHC Carrier Solutions, Inc. (collectively referred to as “Defendants”). The Complaint concerns agreements entered into by Standard Security Life and Madison National Life with Plaintiff, as well as other allegations made by Plaintiff against the Defendants. The Complaint seeks injunctive relief and damages in an amount exceeding $50,000,000, profit share payments allegedly owed to Plaintiff under the agreements totaling at least $3,082,000 through 2014, plus additional amounts for 2015 and 2016, and exemplary and punitive damages as allowed by law and fees and costs. The Defendants moved to Compel Arbitration and Dismiss or Stay the original Complaint. The Plaintiff filed an Amended Complaint on August 18, 2017. The Defendants filed a Motion to Compel Arbitration or Stay the Amended Complaint, which is still pending. In the fourth quarter of 2017, Madison National Life agreed to pay fines in the state of Texas primarily related to the claims payment practices of the Plaintiff. |
Segment Reporting Disclosure _T
Segment Reporting Disclosure [Text Block] | 9 Months Ended |
Sep. 30, 2017 | |
Notes | |
Segment Reporting Disclosure | Note 15. Segment Reporting The Insurance Group principally engages in the life and health insurance business. Interest expense, taxes, and general expenses associated with parent company activities are included in Corporate. Identifiable assets by segment are those assets that are utilized in each segment and are allocated based upon the mean reserves and liabilities of each such segment. Corporate assets are composed principally of cash equivalents, resale agreements, fixed maturities, equity securities, partnership interests and certain other investments. Information by business segment is presented below for the periods indicated (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Revenues: Specialty Health $ 55,502 $ 44,684 $ 152,292 $ 126,454 Group disability; life and DBL 26,112 26,196 78,985 77,409 Individual life, annuities and other (A) 455 717 1,494 2,053 Medical Stop-Loss (A) 576 5,433 2,549 21,397 Corporate 392 620 1,522 2,350 83,037 77,650 236,842 229,663 Net realized investment gains 715 2,367 987 3,945 Net impairment losses recognized in earnings - (1,475) - (1,475) Total revenues $ 83,752 $ 78,542 $ 237,829 $ 232,133 Income from continuing operations before income taxes: Specialty Health (B) $ 5,238 $ 1,369 $ 9,412 $ 3,754 Group disability; life and DBL 5,144 5,323 12,777 13,533 Individual life, annuities and other (A) (C) (385) (410) (532) (1,888) Medical Stop-Loss (A) (538) 2,176 2,752 13,926 Corporate (2,295) (1,908) (6,042) (7,106) 7,164 6,550 18,367 22,219 Net realized investment gains 715 2,367 987 3,945 Net impairment losses recognized in earnings - (1,475) - (1,475) Interest expense - (440) - (1,366) Income from continuing operations before income taxes $ 7,879 $ 7,002 $ 19,354 $ 23,323 (A) (B) (C) |
Organization, Consolidation, 24
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]: Basis of Accounting, Policy [Policy Text Block] (Policies) | 9 Months Ended |
Sep. 30, 2017 | |
Policies | |
Basis of Accounting, Policy | The unaudited Condensed Consolidated Financial Statements have been prepared in conformity with U.S. generally accepted accounting principles ("GAAP") for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X and, therefore, do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements include the accounts of IHC and its consolidated subsidiaries. All significant intercompany transactions have been eliminated in consolidation. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect: (i) the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements; and (ii) the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. IHC’s annual report on Form 10-K as filed with the Securities and Exchange Commission should be read in conjunction with the accompanying unaudited Condensed Consolidated Financial Statements. In the opinion of management, all adjustments (consisting only of normal recurring accruals) that are necessary for a fair presentation of the consolidated financial position and results of operations for the interim periods have been included. The condensed consolidated results of operations for the three months and nine months ended September 30, 2017 are not necessarily indicative of the results to be anticipated for the entire year. |
Organization, Consolidation, 25
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]: New Accounting Pronouncements, Policy [Policy Text Block] (Policies) | 9 Months Ended |
Sep. 30, 2017 | |
Policies | |
New Accounting Pronouncements, Policy | In January 2017, the FASB issued guidance to simplify the test for goodwill impairment by eliminating Step 2 in the goodwill impairment test. Instead, under the amendments in this Update, an entity should perform its annual or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. Additionally, an entity should consider income tax effects from any tax-deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. The amendments in this guidance are effective for public business entities for annual, or any interim, goodwill impairment tests in fiscal years beginning after December 15, 2019. The adoption of this In January 2016, the FASB issued guidance that eliminates the requirement to classify equity securities with readily determinable fair values as trading or available-for-sale. The guidance requires equity securities, other than those that result in consolidation or are accounted for under the equity method, (including other ownership interests, such as partnerships, unincorporated joint ventures, and limited liability companies) to be measured at fair value with changes in the fair value recognized through net income, simplifies the impairment assessment of equity securities without readily determinable fair values and requires changes in disclosure requirements. For public entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption is permitted in certain circumstances. The amendments in this Update should be applied by means of a cumulative-effect adjustment to the balance sheet as of the beginning of the fiscal year of adoption. The amendments related to equity securities without readily determinable fair values (including disclosure requirements) should be applied prospectively to equity investments that exist as of the date of adoption of the guidance. The adoption of this guidance is not expected to have a material effect on the Company’s Consolidated Balance Sheet or IHC’s stockholders’ equity. In May 2014, the FASB issued revenue recognition guidance for entities that either enter into contracts with customers to transfer goods or services or enter into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards such as insurance contracts or lease contracts. The amendment provides specific steps that an entity should apply in order to achieve its main objective which is recognizing revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In 2016, additional guidance and technical corrections were issued to clarify certain aspects of the implementation guidance and to clarify the identification of performance obligations. In August 2015, the effective date of this guidance has been deferred. For public entities, this guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period, and requires one of two specified retrospective methods of application. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. The Company anticipates that any impact will only relate to contracts with customers outside the scope of Accounting Standards Codification Topic 944, Financial Services - Insurance. Our administrative and other service contracts that will be subject to the amendments in this Update are recorded in the Fee Income line item of the Condensed Consolidated Statement of Income and represent approximately 5% of our consolidated revenues for the nine months ended September 30, 2017. The guidance will be applied retrospectively with a cumulative effect adjustment on the date of initial application. Management is still in the process of evaluating the impact that the adoption of this guidance will have on the Company’s consolidated financial statements and does not anticipate any significant changes in internal controls over financial reporting as a result of its implementation. |
Fair Value Disclosures _Text 26
Fair Value Disclosures [Text Block]: Fair Value Transfer, Policy (Policies) | 9 Months Ended |
Sep. 30, 2017 | |
Policies | |
Fair Value Transfer, Policy | It is the Company’s policy to recognize transfers of assets and liabilities between levels of the fair value hierarchy at the end of a reporting period. The Company does not transfer out of Level 3 and into Level 2 until such time as observable inputs become available and reliable or the range of available independent prices narrow. The Company did not transfer any securities between Level 1, Level 2 or Level 3 in either 2017 or 2016. |
Earnings Per Share _Text Bloc27
Earnings Per Share [Text Block]: Schedule of Earnings Per Share, Basic and Diluted (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Tables/Schedules | |
Schedule of Earnings Per Share, Basic and Diluted | Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Income from continuing operations, net of tax $ 5,213 $ 4,366 $ 24,529 $ 14,757 Less: (Income) loss from continuing operations attributable to noncontrolling interests 16 (43) (33) (348) Income from continuing operations attributable to IHC common shareholders $ 5,229 $ 4,323 $ 24,496 $ 14,409 Income from discontinued operations, net of tax $ - $ - $ - $ 109,912 Less: Income from discontinued operations attributable to noncontrolling interests - - - (9,552) Income from discontinued operations attributable to IHC common shareholders $ - $ - $ - $ 100,360 Net income attributable to IHC $ 5,229 $ 4,323 $ 24,496 $ 114,769 |
Disposal Groups, Including Di28
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]: Disposal Groups, Including Discontinued Operations (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Tables/Schedules | |
Disposal Groups, Including Discontinued Operations | Three Months Ended Nine Months Ended September 30, September 30, 2016 2016 Revenue $ - $ 6,406 Selling, general and administrative expenses - 5,689 Pretax profit of discontinued operations - 717 Gain on disposal of discontinued operations, pretax - 116,919 Income from discontinued operations, before income taxes - 117,636 Income taxes (benefits) on discontinued operations - 7,724 Income from discontinued operations $ - $ 109,912 |
Investments in Debt and Marke29
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Schedule of Available-for-sale Securities Reconciliation (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Tables/Schedules | |
Schedule of Available-for-sale Securities Reconciliation | September 30, 2017 GROSS GROSS AMORTIZED UNREALIZED UNREALIZED FAIR COST GAINS LOSSES VALUE FIXED MATURITIES AVAILABLE-FOR-SALE: Corporate securities $ 159,753 $ 894 $ (2,471) $ 158,176 CMOs - residential (1) 7,011 - (106) 6,905 U.S. Government obligations 44,077 57 (257) 43,877 Agency MBS - residential (2) 16 - - 16 GSEs (3) 9,992 1 (211) 9,782 States and political subdivisions 194,724 1,143 (2,828) 193,039 Foreign government obligations 4,276 22 (85) 4,213 Redeemable preferred stocks 10,008 116 (132) 9,992 Total fixed maturities $ 429,857 $ 2,233 $ (6,090) $ 426,000 EQUITY SECURITIES AVAILABLE-FOR-SALE: Common stocks $ 1,612 $ 191 $ (18) $ 1,785 Nonredeemable preferred stocks 3,587 88 - 3,675 Total equity securities $ 5,199 $ 279 $ (18) $ 5,460 December 31, 2016 GROSS GROSS AMORTIZED UNREALIZED UNREALIZED FAIR COST GAINS LOSSES VALUE FIXED MATURITIES AVAILABLE-FOR-SALE: Corporate securities $ 192,976 $ 209 $ (5,490) $ 187,695 CMOs - residential (1) 6,021 8 (116) 5,913 U.S. Government obligations 43,417 133 (441) 43,109 Agency MBS - residential (2) 22 1 - 23 GSEs (3) 10,301 1 (422) 9,880 States and political subdivisions 191,146 780 (5,115) 186,811 Foreign government obligations 5,098 13 (157) 4,954 Redeemable preferred stocks 11,454 96 (448) 11,102 Total fixed maturities $ 460,435 $ 1,241 $ (12,189) $ 449,487 EQUITY SECURITIES AVAILABLE-FOR-SALE: Common stocks $ 1,612 $ 178 $ - $ 1,790 Nonredeemable preferred stocks 3,588 30 (75) 3,543 Total equity securities $ 5,200 $ 208 $ (75) $ 5,333 (1) (2) (3) |
Investments in Debt and Marke30
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Investments Classified by Contractual Maturity Date (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Tables/Schedules | |
Investments Classified by Contractual Maturity Date | AMORTIZED FAIR COST VALUE Due in one year or less $ 29,686 $ 29,631 Due after one year through five years 113,190 112,572 Due after five years through ten years 145,877 145,322 Due after ten years 124,085 121,772 Fixed maturities with no single maturity date 17,019 16,703 $ 429,857 $ 426,000 |
Investments in Debt and Marke31
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Tables/Schedules | |
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | September 30, 2017 Less than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Corporate securities $ 84,636 $ 1,087 $ 25,563 $ 1,384 $ 110,199 $ 2,471 CMOs - residential 4,730 101 2,105 5 6,835 106 U.S. Government obligations 18,021 80 12,619 177 30,640 257 GSEs 3,286 65 6,480 146 9,766 211 States and political subdivisions 88,326 1,413 35,771 1,415 124,097 2,828 Foreign government obligations - - 3,006 85 3,006 85 Redeemable preferred stocks - - 3,631 132 3,631 132 Total fixed maturities 198,999 2,746 89,175 3,344 288,174 6,090 Common stocks 485 18 - - 485 18 Total equity securities 485 18 - - 485 18 Total temporarily impaired securities $ 199,484 $ 2,764 $ 89,175 $ 3,344 $ 288,659 $ 6,108 Number of securities in an unrealized loss position 107 44 151 December 31, 2016 Less than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Corporate securities $ 145,205 $ 3,818 $ 19,841 $ 1,672 $ 165,046 $ 5,490 CMO’s - residential 5,038 116 - - 5,038 116 U.S. Government obligations 28,406 441 - - 28,406 441 GSEs 3,640 166 6,220 256 9,860 422 States and political subdivisions 144,357 4,561 18,132 554 162,489 5,115 Foreign government obligations 3,738 157 - - 3,738 157 Redeemable preferred stocks - - 3,315 448 3,315 448 Total fixed maturities 330,384 9,259 47,508 2,930 377,892 12,189 Nonredeemable preferred stocks 826 25 1,277 50 2,103 75 Total equity securities 826 25 1,277 50 2,103 75 Total temporarily impaired securities $ 331,210 $ 9,284 $ 48,785 $ 2,980 $ 379,995 $ 12,264 Number of securities in an unrealized loss position 156 23 179 |
Investments in Debt and Marke32
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Realized Gain (Loss) on Investments (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Tables/Schedules | |
Realized Gain (Loss) on Investments | Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Available-for-sale securities: Fixed maturities $ 719 $ 2,226 $ 1,062 $ 3,847 Common stocks - 220 - 220 Total available-for-sale securities 719 2,446 1,062 4,067 Trading securities - - - - Total realized gains 719 2,446 1,062 4,067 Unrealized gains (losses) on trading securities: Change in unrealized gains (losses) on trading securities (4) (80) (76) (124) Total unrealized gains (losses) on trading securities (4) (80) (76) (124) Gains (losses) on other investments - 1 1 2 Net realized investment gains $ 715 $ 2,367 $ 987 $ 3,945 |
Investments in Debt and Marke33
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Other than Temporary Impairment, Credit Losses Recognized in Earnings (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Tables/Schedules | |
Other than Temporary Impairment, Credit Losses Recognized in Earnings | Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Balance at beginning of year $ - $ - $ - $ 473 Securities sold - - - (473) Balance at end of period $ - $ - $ - $ - |
Fair Value Disclosures _Text 34
Fair Value Disclosures [Text Block]: Fair Value, Assets Measured on Recurring Basis (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Tables/Schedules | |
Fair Value, Assets Measured on Recurring Basis | September 30, 2017 Level 1 Level 2 Level 3 Total FINANCIAL ASSETS: Fixed maturities available-for-sale: Corporate securities $ - $ 158,176 $ - $ 158,176 CMOs - residential - 6,905 - 6,905 US Government obligations - 43,877 - 43,877 Agency MBS - residential - 16 - 16 GSEs - 9,782 - 9,782 States and political subdivisions - 191,124 1,917 193,041 Foreign government obligations - 4,213 - 4,213 Redeemable preferred stocks 9,990 - - 9,990 Total fixed maturities 9,990 414,093 1,917 426,000 Equity securities available-for-sale: Common stocks 1,785 - - 1,785 Nonredeemable preferred stocks 3,675 - - 3,675 Total equity securities 5,460 - - 5,460 Trading securities - equities 516 - - 516 Total trading securities 516 - - 516 Total Financial Assets $ 15,966 $ 414,093 $ 1,917 $ 431,976 December 31, 2016 Level 1 Level 2 Level 3 Total FINANCIAL ASSETS: Fixed maturities available-for-sale: Corporate securities $ - $ 187,695 $ - $ 187,695 CMOs - residential - 5,913 - 5,913 US Government obligations - 43,109 - 43,109 Agency MBS - residential - 23 - 23 GSEs - 9,880 - 9,880 States and political subdivisions - 184,778 2,033 186,811 Foreign government obligations - 4,954 - 4,954 Redeemable preferred stocks 11,102 - - 11,102 Total fixed maturities 11,102 436,352 2,033 449,487 Equity securities available-for-sale: Common stocks 1,790 - - 1,790 Nonredeemable preferred stocks 3,543 - - 3,543 Total equity securities 5,333 - - 5,333 Trading securities - equities 592 - - 592 Total trading securities 592 - - 592 Total Financial Assets $ 17,027 $ 436,352 $ 2,033 $ 455,412 |
Fair Value Disclosures _Text 35
Fair Value Disclosures [Text Block]: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Tables/Schedules | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation | Three Months Ended September 30, 2017 2016 States and Total States and Total Political Level 3 Political Level 3 Subdivisions Assets Subdivisions Assets Beginning balance $ 1,956 $ 1,956 $ 2,107 $ 2,107 Increases (decreases) recognized in earnings: Net realized investment gains - - - - Gains (losses) included in other comprehensive income (loss): Net unrealized gains (losses) (8) (8) (10) (10) Repayments and amortization of fixed maturities (31) (31) (27) (27) Sales - - - - Balance at end of period $ 1,917 $ 1,917 $ 2,070 $ 2,070 Nine Months Ended September 30, 2017 2016 States and Total States and Total Political Level 3 CMOs Political Level 3 Subdivisions Assets Commercial Subdivisions Assets Beginning balance $ 2,033 $ 2,033 $ 1,195 $ 2,179 $ 3,374 Gains (losses) included in earnings: Net realized investment gains - - 141 - 141 Gains (losses) included in other comprehensive income (loss): Net unrealized gains (losses) (26) (26) (296) (31) (327) Repayments and amortization of fixed maturities (90) (90) (74) (78) (152) Sales - - (966) - (966) Balance at end of period $ 1,917 $ 1,917 $ - $ 2,070 $ 2,070 |
Fair Value Disclosures _Text 36
Fair Value Disclosures [Text Block]: Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Tables/Schedules | |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation | Three Months Ended Nine Months Ended September 30, 2016 September 30, 2016 Total Total Contingent Level 3 Contingent Level 3 Liabilities Liabilities Liabilities Liabilities Beginning balance $ 1,445 $ 1,445 $ 1,650 $ 1,650 Gains (losses) included in earnings: Net investment income (204) (204) (947) (947) Other income (185) (185) 353 353 Payment of contingent liability (700) (700) (700) (700) Balance at end of period $ 356 $ 356 $ 356 $ 356 |
Fair Value Disclosures _Text 37
Fair Value Disclosures [Text Block]: Fair Value, by Balance Sheet Grouping (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Tables/Schedules | |
Fair Value, by Balance Sheet Grouping | September 30, 2017 December 31, 2016 Level 1 Level 2 Level 1 Level 2 Fair Fair Carrying Fair Fair Carrying Value Value Value Value Value Value FINANCIAL ASSETS: Short-term investments $ 50 $ - $ 50 $ 6,912 $ - $ 6,912 FINANCIAL LIABILITIES: Funds on deposit $ - $ 143,911 $ 143,637 $ - $ 146,098 $ 145,749 |
Business Combination Disclosu38
Business Combination Disclosure [Text Block]: Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Tables/Schedules | |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed | Cash $ 390 Intangible assets 5,880 Other assets 567 Total identifiable assets 6,837 Other liabilities 174 Deferred tax liability 1,069 Total liabilities 1,243 Net identifiable assets acquired $ 5,594 Redeemable noncontrolling interest $ 2,005 |
Goodwill and Intangible Asset39
Goodwill and Intangible Assets Disclosure [Text Block]: Schedule of Finite-Lived Intangible Assets (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Tables/Schedules | |
Schedule of Finite-Lived Intangible Assets | September 30, 2017 December 31, 2016 Gross Gross Carrying Accumulated Carrying Accumulated Amount Amortization Amount Amortization Finite-lived Intangible Assets: Agent and broker relationships $ 17,253 $ 11,797 $ 13,052 $ 11,882 Domain 1,000 100 1,000 25 Software systems 780 51 - - Total finite-lived $ 19,033 $ 11,948 $ 14,052 $ 11,907 |
Goodwill and Intangible Asset40
Goodwill and Intangible Assets Disclosure [Text Block]: Schedule of Indefinite-Lived Intangible Assets (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Tables/Schedules | |
Schedule of Indefinite-Lived Intangible Assets | September 30, December 31, 2017 2016 Indefinite-lived Intangible Assets: Insurance licenses $ 7,977 $ 7,977 Total indefinite-lived $ 7,977 $ 7,977 |
Liability for Future Policy B41
Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]: Schedule of Liability for Unpaid Claims and Claims Adjustment Expense (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Schedule of Liability for Unpaid Claims and Claims Adjustment Expense | Nine Months Ended September 30, 2017 2016 Balance at beginning of year $ 219,113 $ 245,443 Less: reinsurance recoverable 88,853 65,362 Net balance at beginning of year 130,260 180,081 Amount incurred, related to: Current year 114,795 111,526 Prior years (9,236) (7,048) Total incurred 105,559 104,478 Amount paid, related to: Current year 52,822 46,997 Prior years 56,452 109,819 Total paid 109,274 156,816 Net balance at end of period 126,545 127,743 Plus: reinsurance recoverable 43,002 115,076 Balance at end of period $ 169,547 $ 242,819 |
Specialty Health Segment Member | Health Insurance Product Line | |
Schedule of Liability for Unpaid Claims and Claims Adjustment Expense | Specialty Health Segment Health Insurance Claims Nine Months Ended September 30, 2017 2016 Balance at beginning of year $ 27,183 $ 23,425 Less: reinsurance recoverable 1,179 1,362 Net balance at beginning of year 26,004 22,063 Amount incurred, related to: Current year 40,836 34,598 Prior years 1,144 (6,845) Total incurred 41,980 27,753 Amount paid, related to: Current year 13,528 9,541 Prior years 23,797 13,105 Total paid 37,325 22,646 Net balance at end of period 30,659 27,170 Plus: reinsurance recoverable 814 848 Balance at end of period $ 31,473 $ 28,018 |
Stockholders' Equity Note Dis42
Stockholders' Equity Note Disclosure [Text Block]: Schedule of Accumulated Other Comprehensive Income (Loss) (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Tables/Schedules | |
Schedule of Accumulated Other Comprehensive Income (Loss) | Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Beginning balance $ (2,504) $ 4,054 $ (6,964) $ (3,440) Other comprehensive income (loss) before reclassifications 627 (182) 5,305 8,522 Amounts reclassified from accumulated OCI (467) (573) (685) (1,618) Net other comprehensive income 160 (755) 4,620 6,904 Less: Other comprehensive income attributable to noncontrolling interests - 47 - (118) Acquired from noncontrolling interests - 102 - 102 Ending balance $ (2,344) $ 3,448 $ (2,344) $ 3,448 |
Stockholders' Equity Note Dis43
Stockholders' Equity Note Disclosure [Text Block]: Reclassification out of Accumulated Other Comprehensive Income (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Tables/Schedules | |
Reclassification out of Accumulated Other Comprehensive Income | Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Unrealized gains (losses) on available-for-sale securities reclassified during the period to the following income statement line items: Net realized investment gains $ 719 $ 2,446 $ 1,062 $ 4,067 Net impairment losses recognized in earnings - (1,475) - (1,475) Income before income tax 719 971 1,062 2,592 Tax effect 252 398 377 974 Net income $ 467 $ 573 $ 685 $ 1,618 |
Compensation and Employee Ben44
Compensation and Employee Benefit Plans [Text Block]: Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Independence Holding Company Share Based Plans Total Member | |
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan | Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 IHC’s Share-based Compensation Plan: Stock options $ 36 $ - $ 106 $ 170 Restricted stock units 23 16 81 60 SARs 305 (57) 359 410 Share-based compensation expense, pre-tax 364 (41) 546 640 Tax benefits 145 16 218 255 Share-based compensation expense, net $ 219 $ (25) $ 328 $ 385 |
Compensation and Employee Ben45
Compensation and Employee Benefit Plans [Text Block]: Schedule of Share-based Compensation, Stock Options, Activity (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Independence Holding Company Share Based Plans Total Member | |
Schedule of Share-based Compensation, Stock Options, Activity | Shares Weighted- Average Under Option Exercise Price December 31, 2016 697,180 $ 11.75 Granted 34,000 22.20 Exercised (38,800) 9.09 September 30, 2017 692,380 $ 12.41 |
Compensation and Employee Ben46
Compensation and Employee Benefit Plans [Text Block]: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Independence Holding Company Share Based Plans Total Member | |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions | 2017 Weighted-average risk-free interest rate 1.71% Expected annual dividend rate per share 0.79% Expected volatility factor of the Company's common stock 37.57% Weighted-average expected term of options 4.5 years |
Compensation and Employee Ben47
Compensation and Employee Benefit Plans [Text Block]: Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Independence Holding Company Share Based Plans Total Member | |
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding | September 30, 2017 Outstanding Exercisable Number of options 692,380 501,380 Weighted average exercise price per share $ 12.41 $ 9.39 Aggregate intrinsic value for all options (in thousands) $ 8,889 $ 7,953 Weighted average contractual term remaining 1.9 years 1.0 years |
Compensation and Employee Ben48
Compensation and Employee Benefit Plans [Text Block]: Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Tables/Schedules | |
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity | No. of Weighted-Average Non-vested Grant-Date Shares Fair Value December 31, 2016 17,325 $ 16.20 Vested (4,950) 12.53 September 30, 2017 12,375 $ 17.68 |
Segment Reporting Disclosure 49
Segment Reporting Disclosure [Text Block]: Schedule of Segment Reporting Information, by Segment (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Tables/Schedules | |
Schedule of Segment Reporting Information, by Segment | Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Revenues: Specialty Health $ 55,502 $ 44,684 $ 152,292 $ 126,454 Group disability; life and DBL 26,112 26,196 78,985 77,409 Individual life, annuities and other (A) 455 717 1,494 2,053 Medical Stop-Loss (A) 576 5,433 2,549 21,397 Corporate 392 620 1,522 2,350 83,037 77,650 236,842 229,663 Net realized investment gains 715 2,367 987 3,945 Net impairment losses recognized in earnings - (1,475) - (1,475) Total revenues $ 83,752 $ 78,542 $ 237,829 $ 232,133 Income from continuing operations before income taxes: Specialty Health (B) $ 5,238 $ 1,369 $ 9,412 $ 3,754 Group disability; life and DBL 5,144 5,323 12,777 13,533 Individual life, annuities and other (A) (C) (385) (410) (532) (1,888) Medical Stop-Loss (A) (538) 2,176 2,752 13,926 Corporate (2,295) (1,908) (6,042) (7,106) 7,164 6,550 18,367 22,219 Net realized investment gains 715 2,367 987 3,945 Net impairment losses recognized in earnings - (1,475) - (1,475) Interest expense - (440) - (1,366) Income from continuing operations before income taxes $ 7,879 $ 7,002 $ 19,354 $ 23,323 (A) (B) (C) |
Organization, Consolidation, 50
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] (Details) - USD ($) $ in Thousands | 1 Months Ended | 9 Months Ended | |
Aug. 31, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Cash paid in acquisitions of noncontrolling interests | $ 0 | $ 18,141 | |
GeneveAffiliatedEntityMember | |||
EntityCommonStockOutstandingOwnershipPercent | 6100.00% | ||
AMICSubsidiariesMember | |||
Cash paid in acquisitions of noncontrolling interests | $ 18,141 | ||
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase of Interest by Parent | $ 2,230 |
Organization, Consolidation, 51
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]: New Accounting Pronouncements, Policy [Policy Text Block] (Details) | 9 Months Ended |
Sep. 30, 2017 | |
Fee Income Member | |
Income Statement Line Item Expressed As Percent Of Revenue | 500.00% |
Earnings Per Share _Text Bloc52
Earnings Per Share [Text Block] (Details) - shares shares in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Details | ||||
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | 309 | 220 | 288 | 213 |
Earnings Per Share _Text Bloc53
Earnings Per Share [Text Block]: Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Details | ||||
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $ 5,213 | $ 4,366 | $ 24,529 | $ 14,757 |
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest | (16) | 43 | 33 | 348 |
Income (Loss) from Continuing Operations Attributable to Parent | 5,229 | 4,323 | 24,496 | 14,409 |
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | 0 | 0 | 0 | 109,912 |
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Noncontrolling Interest | 0 | 0 | 0 | 9,552 |
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | 0 | 0 | 0 | 100,360 |
Net Income (Loss) Attributable to Parent, Total | $ 5,229 | $ 4,323 | $ 24,496 | $ 114,769 |
Disposal Groups, Including Di54
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | Dec. 31, 2016 | Mar. 31, 2016 | |
Disposal Group, Including Discontinued Operation, Liabilities | $ 0 | $ 0 | $ 68 | |||
Cash Provided by (Used in) Operating Activities, Discontinued Operations | $ 0 | $ 339 | ||||
Discontinued Operation, Tax Effect of Discontinued Operation | 0 | 0 | 0 | 7,724 | ||
Risk Solutions Sale and Coinsurance Transaction Member | AMICSubsidiariesMember | ||||||
Aggregate Consideration Allocated To An Entity, Expressed As A Percent | 8900.00% | |||||
Risk Solutions Sale and Coinsurance Transaction Member | Medical Stop-Loss Segment Member | ||||||
Disposal Group, Including Discontinued Operation, Liabilities | $ 0 | $ 0 | $ 68 | |||
Risk Solutions Sale and Coinsurance Transaction Member | Discontinued Operations, Disposed of by Sale | ||||||
Discontinued Operation, Tax Effect of Discontinued Operation | 7,724 | |||||
Risk Solutions Sale and Coinsurance Transaction Member | Discontinued Operations, Disposed of by Sale | State and Local Jurisdiction | ||||||
Discontinued Operation, Tax Effect of Discontinued Operation | 5,777 | |||||
Risk Solutions Sale and Coinsurance Transaction Member | Discontinued Operations, Disposed of by Sale | Domestic Tax Authority | ||||||
Discontinued Operation, Tax Effect of Discontinued Operation | 1,947 | |||||
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | (38,419) | |||||
Risk Solutions Sale and Coinsurance Transaction Member | Discontinued Operations, Disposed of by Sale | Medical Stop-Loss Segment Member | ||||||
Disposal Group, Including Discontinued Operation, Consideration | $ 152,500 | |||||
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax, Portion Attributable to Parent | 99,934 | |||||
Discontinued Operation, Tax Effect of Discontinued Operation | $ 0 | $ 7,724 |
Disposal Groups, Including Di55
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]: Disposal Groups, Including Discontinued Operations (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax | $ 0 | $ 0 | $ 0 | $ 117,636 |
Discontinued Operation, Tax Effect of Discontinued Operation | 0 | 0 | 0 | 7,724 |
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $ 0 | 0 | $ 0 | 109,912 |
Risk Solutions Sale and Coinsurance Transaction Member | Discontinued Operations, Disposed of by Sale | ||||
Discontinued Operation, Tax Effect of Discontinued Operation | 7,724 | |||
Risk Solutions Sale and Coinsurance Transaction Member | Discontinued Operations, Disposed of by Sale | Medical Stop-Loss Segment Member | ||||
Disposal Group, Including Discontinued Operation, Revenue | 0 | 6,406 | ||
Disposal Group, Including Discontinued Operation, General and Administrative Expense | 0 | 5,689 | ||
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax | 0 | 717 | ||
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax | 0 | 116,919 | ||
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax | 0 | 117,636 | ||
Discontinued Operation, Tax Effect of Discontinued Operation | 0 | 7,724 | ||
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $ 0 | $ 109,912 |
Investments in Debt and Marke56
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Schedule of Available-for-sale Securities Reconciliation (Details) - USD ($) $ in Thousands | Sep. 30, 2017 | Dec. 31, 2016 |
Available For Sale Debt Securities Amortized Cost Basis | $ 429,857 | $ 460,435 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax | 2,233 | 1,241 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax | 6,090 | 12,189 |
Available-for-sale Securities, Debt Securities | 426,000 | 449,487 |
Available For Sale Equity Securities Amortized Cost Basis | 5,199 | 5,200 |
Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax | 279 | 208 |
Available-for-sale Equity Securities, Accumulated Gross Unrealized Loss, before Tax | 18 | 75 |
Available-for-sale Securities, Equity Securities | 5,460 | 5,333 |
Corporate Debt Securities | ||
Available For Sale Debt Securities Amortized Cost Basis | 159,753 | 192,976 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax | 894 | 209 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax | 2,471 | 5,490 |
Available-for-sale Securities, Debt Securities | 158,176 | 187,695 |
Residential Mortgage Backed Securities | ||
Available For Sale Debt Securities Amortized Cost Basis | 7,011 | 6,021 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax | 0 | 8 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax | 106 | 116 |
Available-for-sale Securities, Debt Securities | 6,905 | 5,913 |
US Treasury Securities | ||
Available For Sale Debt Securities Amortized Cost Basis | 44,077 | 43,417 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax | 57 | 133 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax | 257 | 441 |
Available-for-sale Securities, Debt Securities | 43,877 | 43,109 |
US Government Agencies Debt Securities | ||
Available For Sale Debt Securities Amortized Cost Basis | 16 | 22 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax | 0 | 1 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax | 0 | 0 |
Available-for-sale Securities, Debt Securities | 16 | 23 |
US Government-sponsored Enterprises Debt Securities | ||
Available For Sale Debt Securities Amortized Cost Basis | 9,992 | 10,301 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax | 1 | 1 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax | 211 | 422 |
Available-for-sale Securities, Debt Securities | 9,782 | 9,880 |
US States and Political Subdivisions Debt Securities | ||
Available For Sale Debt Securities Amortized Cost Basis | 194,724 | 191,146 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax | 1,143 | 780 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax | 2,828 | 5,115 |
Available-for-sale Securities, Debt Securities | 193,039 | 186,811 |
Foreign Government Debt | ||
Available For Sale Debt Securities Amortized Cost Basis | 4,276 | 5,098 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax | 22 | 13 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax | 85 | 157 |
Available-for-sale Securities, Debt Securities | 4,213 | 4,954 |
Redeemable Preferred Stock | ||
Available For Sale Debt Securities Amortized Cost Basis | 10,008 | 11,454 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax | 116 | 96 |
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax | 132 | 448 |
Available-for-sale Securities, Debt Securities | 9,992 | 11,102 |
Common Stock | ||
Available For Sale Equity Securities Amortized Cost Basis | 1,612 | 1,612 |
Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax | 191 | 178 |
Available-for-sale Equity Securities, Accumulated Gross Unrealized Loss, before Tax | 18 | 0 |
Available-for-sale Securities, Equity Securities | 1,785 | 1,790 |
Nonredeemable Preferred Stock | ||
Available For Sale Equity Securities Amortized Cost Basis | 3,587 | 3,588 |
Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax | 88 | 30 |
Available-for-sale Equity Securities, Accumulated Gross Unrealized Loss, before Tax | 0 | 75 |
Available-for-sale Securities, Equity Securities | $ 3,675 | $ 3,543 |
Investments in Debt and Marke57
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Investments Classified by Contractual Maturity Date (Details) - USD ($) $ in Thousands | Sep. 30, 2017 | Dec. 31, 2016 |
Details | ||
Available-for-sale Securities, Debt Maturities, Next Twelve Months, Amortized Cost Basis | $ 29,686 | |
Available-for-sale Securities, Debt Maturities, Next Twelve Months, Fair Value | 29,631 | |
Available-for-sale Securities, Debt Maturities, Year Two Through Five, Amortized Cost Basis | 113,190 | |
Available-for-sale Securities, Debt Maturities, Year Two Through Five, Fair Value | 112,572 | |
Available-for-sale Securities, Debt Maturities, Year Six Through Ten, Amortized Cost Basis | 145,877 | |
Available-for-sale Securities, Debt Maturities, Year Six Through Ten, Fair Value | 145,322 | |
Available-for-sale Securities, Debt Maturities, after Ten Years, Amortized Cost Basis | 124,085 | |
Available-for-sale Securities, Debt Maturities, after Ten Years, Fair Value | 121,772 | |
Available-for-sale Securities, Debt Maturities, without Single Maturity Date, Amortized Cost Basis | 17,019 | |
Available-for-sale Securities, Debt Maturities, without Single Maturity Date, Fair Value | 16,703 | |
Available For Sale Debt Securities Amortized Cost Basis | 429,857 | $ 460,435 |
Available-for-sale Securities, Debt Securities | $ 426,000 | $ 449,487 |
Investments in Debt and Marke58
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value (Details) $ in Thousands | Sep. 30, 2017USD ($) | Dec. 31, 2016USD ($) |
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value | $ 199,484 | $ 331,210 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 2,764 | 9,284 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | 89,175 | 48,785 |
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 3,344 | 2,980 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | 288,659 | 379,995 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss | $ 6,108 | $ 12,264 |
Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Less than One Year | 107 | 156 |
Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Greater than or Equal to One Year | 44 | 23 |
Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions | 151 | 179 |
Corporate Debt Securities | ||
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value | $ 84,636 | $ 145,205 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 1,087 | 3,818 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | 25,563 | 19,841 |
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 1,384 | 1,672 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | 110,199 | 165,046 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss | 2,471 | 5,490 |
Residential Mortgage Backed Securities | ||
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value | 4,730 | 5,038 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 101 | 116 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | 2,105 | 0 |
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 5 | 0 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | 6,835 | 5,038 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss | 106 | 116 |
US Treasury Securities | ||
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value | 18,021 | 28,406 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 80 | 441 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | 12,619 | 0 |
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 177 | 0 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | 30,640 | 28,406 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss | 257 | 441 |
US Government-sponsored Enterprises Debt Securities | ||
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value | 3,286 | 3,640 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 65 | 166 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | 6,480 | 6,220 |
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 146 | 256 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | 9,766 | 9,860 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss | 211 | 422 |
US States and Political Subdivisions Debt Securities | ||
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value | 88,326 | 144,357 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 1,413 | 4,561 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | 35,771 | 18,132 |
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 1,415 | 554 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | 124,097 | 162,489 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss | 2,828 | 5,115 |
Foreign Government Debt | ||
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value | 0 | 3,738 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 0 | 157 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | 3,006 | 0 |
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 85 | 0 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | 3,006 | 3,738 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss | 85 | 157 |
Redeemable Preferred Stock | ||
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value | 0 | 0 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 0 | 0 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | 3,631 | 3,315 |
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 132 | 448 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | 3,631 | 3,315 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss | 132 | 448 |
Debt Securities | ||
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value | 198,999 | 330,384 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 2,746 | 9,259 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | 89,175 | 47,508 |
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 3,344 | 2,930 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | 288,174 | 377,892 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss | 6,090 | 12,189 |
Common Stock | ||
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value | 485 | |
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 18 | |
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | 0 | |
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 0 | |
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | 485 | |
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss | 18 | |
Equity Securities | ||
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value | 485 | 826 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 18 | 25 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | 0 | 1,277 |
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 0 | 50 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | 485 | 2,103 |
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss | $ 18 | 75 |
Nonredeemable Preferred Stock | ||
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value | 826 | |
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 25 | |
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | 1,277 | |
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 50 | |
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | 2,103 | |
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss | $ 75 |
Investments in Debt and Marke59
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Realized Gain (Loss) on Investments (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Available for sale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments | $ 719 | $ 2,446 | $ 1,062 | $ 4,067 |
Trading Securities, Realized Gain (Loss) | 0 | 0 | 0 | 0 |
Marketable Securities, Realized Gain (Loss), Excluding Other than Temporary Impairments | 719 | 2,446 | 1,062 | 4,067 |
Trading Securities, Change in Unrealized Holding Gain (Loss) | (4) | (80) | (76) | (124) |
Marketable Securities, Unrealized Gain (Loss), Excluding Other than Temporary Impairments | (4) | (80) | (76) | (124) |
Gain (Loss) on Sale of Other Investments | 0 | 1 | 1 | 2 |
Gain (Loss) on Investments, Excluding Other than Temporary Impairments | 715 | 2,367 | 987 | 3,945 |
Debt Securities | ||||
Available for sale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments | 719 | 2,226 | 1,062 | 3,847 |
Common Stock | ||||
Available for sale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments | $ 0 | $ 220 | $ 0 | $ 220 |
Investments in Debt and Marke60
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Details | ||||
Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds | $ 29,564 | $ 179,735 | $ 157,541 | $ 339,171 |
Available-for-sale Securities, Gross Realized Gains | 747 | 2,668 | 2,052 | 4,521 |
Available-for-sale Securities, Gross Realized Losses | 0 | 94 | 844 | 275 |
Net impairment losses recognized in earnings | $ 0 | $ 1,475 | $ 0 | $ 1,475 |
Investments in Debt and Marke61
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Other than Temporary Impairment, Credit Losses Recognized in Earnings (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Details | ||||
Other than Temporary Impairment, Credit Losses Recognized in Earnings, Credit Losses on Debt Securities Held | $ 0 | $ 0 | $ 0 | $ 473 |
Other than Temporary Impairment, Credit Losses Recognized in Earnings, Reductions, Securities Sold | 0 | 0 | 0 | (473) |
Other than Temporary Impairment, Credit Losses Recognized in Earnings, Credit Losses on Debt Securities Held | $ 0 | $ 0 | $ 0 | $ 0 |
Fair Value Disclosures _Text 62
Fair Value Disclosures [Text Block]: Fair Value, Assets Measured on Recurring Basis (Details) - USD ($) $ in Thousands | Sep. 30, 2017 | Dec. 31, 2016 |
Available-for-sale Securities, Debt Securities | $ 426,000 | $ 449,487 |
Available-for-sale Securities, Equity Securities | 5,460 | 5,333 |
Trading Securities | 516 | 592 |
Corporate Debt Securities | ||
Available-for-sale Securities, Debt Securities | 158,176 | 187,695 |
Residential Mortgage Backed Securities | ||
Available-for-sale Securities, Debt Securities | 6,905 | 5,913 |
US Treasury Securities | ||
Available-for-sale Securities, Debt Securities | 43,877 | 43,109 |
US Government Agencies Debt Securities | ||
Available-for-sale Securities, Debt Securities | 16 | 23 |
US Government-sponsored Enterprises Debt Securities | ||
Available-for-sale Securities, Debt Securities | 9,782 | 9,880 |
US States and Political Subdivisions Debt Securities | ||
Available-for-sale Securities, Debt Securities | 193,039 | 186,811 |
Foreign Government Debt | ||
Available-for-sale Securities, Debt Securities | 4,213 | 4,954 |
Redeemable Preferred Stock | ||
Available-for-sale Securities, Debt Securities | 9,992 | 11,102 |
Common Stock | ||
Available-for-sale Securities, Equity Securities | 1,785 | 1,790 |
Nonredeemable Preferred Stock | ||
Available-for-sale Securities, Equity Securities | 3,675 | 3,543 |
Fair Value, Measurements, Recurring | ||
Available-for-sale Securities, Debt Securities | 426,000 | 449,487 |
Available-for-sale Securities, Equity Securities | 5,460 | 5,333 |
Trading Securities | 516 | 592 |
Assets, Fair Value Disclosure, Recurring | 431,976 | 455,412 |
Fair Value, Measurements, Recurring | Corporate Debt Securities | ||
Available-for-sale Securities, Debt Securities | 158,176 | 187,695 |
Fair Value, Measurements, Recurring | Residential Mortgage Backed Securities | ||
Available-for-sale Securities, Debt Securities | 6,905 | 5,913 |
Fair Value, Measurements, Recurring | US Treasury Securities | ||
Available-for-sale Securities, Debt Securities | 43,877 | 43,109 |
Fair Value, Measurements, Recurring | US Government Agencies Debt Securities | ||
Available-for-sale Securities, Debt Securities | 16 | 23 |
Fair Value, Measurements, Recurring | US Government-sponsored Enterprises Debt Securities | ||
Available-for-sale Securities, Debt Securities | 9,782 | 9,880 |
Fair Value, Measurements, Recurring | US States and Political Subdivisions Debt Securities | ||
Available-for-sale Securities, Debt Securities | 193,041 | 186,811 |
Fair Value, Measurements, Recurring | Foreign Government Debt | ||
Available-for-sale Securities, Debt Securities | 4,213 | 4,954 |
Fair Value, Measurements, Recurring | Redeemable Preferred Stock | ||
Available-for-sale Securities, Debt Securities | 9,990 | 11,102 |
Fair Value, Measurements, Recurring | Common Stock | ||
Available-for-sale Securities, Equity Securities | 1,785 | 1,790 |
Fair Value, Measurements, Recurring | Nonredeemable Preferred Stock | ||
Available-for-sale Securities, Equity Securities | 3,675 | 3,543 |
Fair Value, Measurements, Recurring | Equity Securities | ||
Trading Securities | 516 | 592 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | ||
Available-for-sale Securities, Debt Securities | 9,990 | 11,102 |
Available-for-sale Securities, Equity Securities | 5,460 | 5,333 |
Trading Securities | 516 | 592 |
Assets, Fair Value Disclosure, Recurring | 15,966 | 17,027 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | Corporate Debt Securities | ||
Available-for-sale Securities, Debt Securities | 0 | 0 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | Residential Mortgage Backed Securities | ||
Available-for-sale Securities, Debt Securities | 0 | 0 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | US Treasury Securities | ||
Available-for-sale Securities, Debt Securities | 0 | 0 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | US Government Agencies Debt Securities | ||
Available-for-sale Securities, Debt Securities | 0 | 0 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | US Government-sponsored Enterprises Debt Securities | ||
Available-for-sale Securities, Debt Securities | 0 | 0 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | US States and Political Subdivisions Debt Securities | ||
Available-for-sale Securities, Debt Securities | 0 | 0 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | Foreign Government Debt | ||
Available-for-sale Securities, Debt Securities | 0 | 0 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | Redeemable Preferred Stock | ||
Available-for-sale Securities, Debt Securities | 9,990 | 11,102 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | Common Stock | ||
Available-for-sale Securities, Equity Securities | 1,785 | 1,790 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | Nonredeemable Preferred Stock | ||
Available-for-sale Securities, Equity Securities | 3,675 | 3,543 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | Equity Securities | ||
Trading Securities | 516 | 592 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | ||
Available-for-sale Securities, Debt Securities | 414,093 | 436,352 |
Available-for-sale Securities, Equity Securities | 0 | 0 |
Trading Securities | 0 | 0 |
Assets, Fair Value Disclosure, Recurring | 414,093 | 436,352 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | Corporate Debt Securities | ||
Available-for-sale Securities, Debt Securities | 158,176 | 187,695 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | Residential Mortgage Backed Securities | ||
Available-for-sale Securities, Debt Securities | 6,905 | 5,913 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | US Treasury Securities | ||
Available-for-sale Securities, Debt Securities | 43,877 | 43,109 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | US Government Agencies Debt Securities | ||
Available-for-sale Securities, Debt Securities | 16 | 23 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | US Government-sponsored Enterprises Debt Securities | ||
Available-for-sale Securities, Debt Securities | 9,782 | 9,880 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | US States and Political Subdivisions Debt Securities | ||
Available-for-sale Securities, Debt Securities | 191,124 | 184,778 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | Foreign Government Debt | ||
Available-for-sale Securities, Debt Securities | 4,213 | 4,954 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | Redeemable Preferred Stock | ||
Available-for-sale Securities, Debt Securities | 0 | 0 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | Common Stock | ||
Available-for-sale Securities, Equity Securities | 0 | 0 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | Nonredeemable Preferred Stock | ||
Available-for-sale Securities, Equity Securities | 0 | 0 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | Equity Securities | ||
Trading Securities | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | ||
Available-for-sale Securities, Debt Securities | 1,917 | 2,033 |
Available-for-sale Securities, Equity Securities | 0 | 0 |
Trading Securities | 0 | 0 |
Assets, Fair Value Disclosure, Recurring | 1,917 | 2,033 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | Corporate Debt Securities | ||
Available-for-sale Securities, Debt Securities | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | Residential Mortgage Backed Securities | ||
Available-for-sale Securities, Debt Securities | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | US Treasury Securities | ||
Available-for-sale Securities, Debt Securities | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | US Government Agencies Debt Securities | ||
Available-for-sale Securities, Debt Securities | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | US Government-sponsored Enterprises Debt Securities | ||
Available-for-sale Securities, Debt Securities | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | US States and Political Subdivisions Debt Securities | ||
Available-for-sale Securities, Debt Securities | 1,917 | 2,033 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | Foreign Government Debt | ||
Available-for-sale Securities, Debt Securities | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | Redeemable Preferred Stock | ||
Available-for-sale Securities, Debt Securities | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | Common Stock | ||
Available-for-sale Securities, Equity Securities | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | Nonredeemable Preferred Stock | ||
Available-for-sale Securities, Equity Securities | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | Equity Securities | ||
Trading Securities | $ 0 | $ 0 |
Fair Value Disclosures _Text 63
Fair Value Disclosures [Text Block]: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | $ 1,956 | $ 2,107 | $ 2,033 | $ 3,374 |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) | (8) | (10) | (26) | (327) |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements | (31) | (27) | (90) | (152) |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales | 0 | 0 | 0 | (966) |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | 1,917 | 2,070 | 1,917 | 2,070 |
Net realized investment gains | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings | 0 | 0 | 0 | 141 |
US States and Political Subdivisions Debt Securities | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | 1,956 | 2,107 | 2,033 | 2,179 |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) | (8) | (10) | (26) | (31) |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements | (31) | (27) | (90) | (78) |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales | 0 | 0 | 0 | 0 |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | 1,917 | 2,070 | 1,917 | 2,070 |
US States and Political Subdivisions Debt Securities | Net realized investment gains | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings | $ 0 | 0 | $ 0 | 0 |
Commercial Mortgage Backed Securities | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | 1,195 | |||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) | (296) | |||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements | (74) | |||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales | (966) | |||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | $ 0 | 0 | ||
Commercial Mortgage Backed Securities | Net realized investment gains | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings | $ 141 |
Fair Value Disclosures _Text 64
Fair Value Disclosures [Text Block]: Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended |
Sep. 30, 2016 | Sep. 30, 2016 | |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | $ 1,445 | $ 1,650 |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements | (700) | (700) |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | 356 | 356 |
Investment Income | ||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings | (204) | (947) |
Other Income | ||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings | (185) | 353 |
Contingent Liability Member | ||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | 1,445 | 1,650 |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements | (700) | (700) |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | 356 | 356 |
Contingent Liability Member | Investment Income | ||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings | (204) | (947) |
Contingent Liability Member | Other Income | ||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings | $ (185) | $ 353 |
Fair Value Disclosures _Text 65
Fair Value Disclosures [Text Block]: Fair Value, by Balance Sheet Grouping (Details) - USD ($) $ in Thousands | Sep. 30, 2017 | Dec. 31, 2016 |
Short-term investments | $ 50 | $ 6,912 |
Deposit Contracts, Liabilities | 143,637 | 145,749 |
Estimate of Fair Value Measurement | Fair Value, Inputs, Level 1 | ||
Short-term investments | 50 | 6,912 |
Deposit Contracts, Liabilities | 0 | 0 |
Estimate of Fair Value Measurement | Fair Value, Inputs, Level 2 | ||
Short-term investments | 0 | 0 |
Deposit Contracts, Liabilities | 143,911 | 146,098 |
Reported Value Measurement | ||
Short-term investments | 50 | 6,912 |
Deposit Contracts, Liabilities | $ 143,637 | $ 145,749 |
Variable Interest Entity Disc66
Variable Interest Entity Disclosure [Text Block] (Details) $ in Thousands | Sep. 30, 2017USD ($) |
Variable Interest Entity, Not Primary Beneficiary, Aggregated Disclosure | Other Investments | |
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount | $ 4,141 |
Business Combination Disclosu67
Business Combination Disclosure [Text Block] (Details) - USD ($) $ in Thousands | 1 Months Ended | 3 Months Ended | 4 Months Ended | 9 Months Ended | |||
Mar. 31, 2017 | Sep. 30, 2017 | Sep. 30, 2016 | Jun. 30, 2017 | Sep. 30, 2017 | Sep. 30, 2016 | Mar. 24, 2017 | |
Revenues | $ 83,752 | $ 78,542 | $ 237,829 | $ 232,133 | |||
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total | 5,213 | $ 4,366 | $ 24,529 | $ 124,669 | |||
PetPartnersIncAcquiree,Member | |||||||
Business Acquisition, Percentage of Voting Interests Acquired | 8500.00% | ||||||
Business Combination, Consideration Transferred | $ 12,713 | ||||||
Goodwill, Acquired During Period | $ 9,124 | ||||||
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles | $ 5,880 | ||||||
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value | 2,005 | ||||||
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net | $ 5,594 | ||||||
Revenues | 1,416 | $ 2,869 | |||||
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total | $ 112 | $ 199 |
Business Combination Disclosu68
Business Combination Disclosure [Text Block]: Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - PetPartnersIncAcquiree,Member $ in Thousands | Mar. 24, 2017USD ($) |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents | $ 390 |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles | 5,880 |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other | 567 |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets | 6,837 |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other | 174 |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities | 1,069 |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities | 1,243 |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net | 5,594 |
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value | $ 2,005 |
Goodwill and Intangible Asset69
Goodwill and Intangible Assets Disclosure [Text Block] (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | Dec. 31, 2016 | |
Goodwill | $ 50,697 | $ 50,697 | $ 41,573 | ||
Intangible Assets, Net (Excluding Goodwill) | 15,062 | 15,062 | $ 10,122 | ||
Amortization of Intangible Assets | 393 | $ 366 | 941 | $ 1,057 | |
Specialty Health Segment Member | |||||
Goodwill, Acquired During Period | 9,124 | ||||
Finite-lived Intangible Assets Acquired | $ 5,880 | ||||
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life | 9 years 7 months 6 days | ||||
Amortization of Intangible Assets | $ 393 | $ 366 | $ 941 | $ 1,057 |
Goodwill and Intangible Asset70
Goodwill and Intangible Assets Disclosure [Text Block]: Schedule of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands | Sep. 30, 2017 | Dec. 31, 2016 |
Finite-Lived Intangible Assets, Gross | $ 19,033 | $ 14,052 |
Finite-Lived Intangible Assets, Accumulated Amortization | 11,948 | 11,907 |
Customer Relationships | ||
Finite-Lived Intangible Assets, Gross | 17,253 | 13,052 |
Finite-Lived Intangible Assets, Accumulated Amortization | 11,797 | 11,882 |
Internet Domain Names | ||
Finite-Lived Intangible Assets, Gross | 1,000 | 1,000 |
Finite-Lived Intangible Assets, Accumulated Amortization | 100 | 25 |
Computer Software, Intangible Asset | ||
Finite-Lived Intangible Assets, Gross | 780 | 0 |
Finite-Lived Intangible Assets, Accumulated Amortization | $ 51 | $ 0 |
Goodwill and Intangible Asset71
Goodwill and Intangible Assets Disclosure [Text Block]: Schedule of Indefinite-Lived Intangible Assets (Details) - USD ($) $ in Thousands | Sep. 30, 2017 | Dec. 31, 2016 |
Indefinite-Lived Intangible Assets (Excluding Goodwill) | $ 7,977 | $ 7,977 |
Licensing Agreements | ||
Indefinite-Lived Intangible Assets (Excluding Goodwill) | $ 7,977 | $ 7,977 |
Income Tax Disclosure _Text B72
Income Tax Disclosure [Text Block] (Details) $ in Thousands | 9 Months Ended |
Sep. 30, 2017USD ($) | |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | 3500.00% |
IHC Administrative Services Inc.Member | |
Effective Income Tax Rate Reconciliation, Subsidiary Stock Basis Write Off | $ 11,589 |
Income Tax Deduction On Subsidiary Stock Basis Write Off | $ 33,110 |
Liability for Future Policy B73
Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]: Schedule of Liability for Unpaid Claims and Claims Adjustment Expense (Details) - USD ($) $ in Thousands | 9 Months Ended | |||
Sep. 30, 2017 | Sep. 30, 2016 | Dec. 31, 2016 | Dec. 31, 2015 | |
Liability for Claims and Claims Adjustment Expense, Beginning Balance | $ 219,113 | $ 245,443 | ||
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Beginning Balance | 88,853 | 65,362 | ||
Liability for Unpaid Claims and Claims Adjustment Expense, Net | 126,545 | 127,743 | $ 130,260 | $ 180,081 |
Current Year Claims and Claims Adjustment Expense | 114,795 | 111,526 | ||
Prior Year Claims and Claims Adjustment Expense | (9,236) | (7,048) | ||
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims | 105,559 | 104,478 | ||
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year | 52,822 | 46,997 | ||
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years | 56,452 | 109,819 | ||
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid | 109,274 | 156,816 | ||
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Ending Balance | 43,002 | 115,076 | ||
Liability for Claims and Claims Adjustment Expense, Ending Balance | 169,547 | 242,819 | ||
Specialty Health Segment Member | ||||
Prior Year Claims and Claims Adjustment Expense | 1,304 | (3,769) | ||
Specialty Health Segment Member | Health Insurance Product Line | ||||
Liability for Claims and Claims Adjustment Expense, Beginning Balance | 27,183 | 23,425 | ||
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Beginning Balance | 1,179 | 1,362 | ||
Liability for Unpaid Claims and Claims Adjustment Expense, Net | 30,659 | 27,170 | $ 26,004 | $ 22,063 |
Current Year Claims and Claims Adjustment Expense | 40,836 | 34,598 | ||
Prior Year Claims and Claims Adjustment Expense | 1,144 | (6,845) | ||
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims | 41,980 | 27,753 | ||
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year | 13,528 | 9,541 | ||
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years | 23,797 | 13,105 | ||
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid | 37,325 | 22,646 | ||
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Ending Balance | 814 | 848 | ||
Liability for Claims and Claims Adjustment Expense, Ending Balance | $ 31,473 | $ 28,018 |
Liability for Future Policy B74
Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block] (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2017 | Sep. 30, 2016 | |
Prior Year Claims and Claims Adjustment Expense | $ (9,236) | $ (7,048) |
Medical Stop-Loss Segment Member | ||
Prior Year Claims and Claims Adjustment Expense | (2,420) | (494) |
Group disability, life and DBL Segment Member | ||
Prior Year Claims and Claims Adjustment Expense | (5,406) | (2,916) |
Individual life annuities and other Segment Member | ||
Prior Year Claims and Claims Adjustment Expense | (2,714) | |
Specialty Health Segment Member | ||
Prior Year Claims and Claims Adjustment Expense | 1,304 | (3,769) |
Specialty Health Segment Member | Health Insurance Product Line | ||
Prior Year Claims and Claims Adjustment Expense | 1,144 | $ (6,845) |
Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net | $ 30,659 |
Stockholders' Equity Note Dis75
Stockholders' Equity Note Disclosure [Text Block] (Details) $ in Thousands | 9 Months Ended |
Sep. 30, 2017USD ($)shares | |
Treasury Stock, Shares, Acquired | shares | 2,211,629 |
Treasury Stock, Value, Acquired, Cost Method | $ | $ 44,442 |
Treasury Stock | |
Treasury Stock, Value, Acquired, Cost Method | $ | $ 44,442 |
Stock Issued During Period, Shares, Share-based Compensation, Gross | shares | 12,671 |
Private Placement Member | |
Treasury Stock, Shares, Acquired | shares | 703,000 |
Treasury Stock, Value, Acquired, Cost Method | $ | $ 13,975 |
Tender Offer | |
Treasury Stock, Shares, Acquired | shares | 1,385,118 |
Treasury Stock, Value, Acquired, Cost Method | $ | $ 27,702 |
Stockholders' Equity Note Dis76
Stockholders' Equity Note Disclosure [Text Block]: Schedule of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Accumulated other comprehensive income (loss) | $ (6,964) | |||
Other Comprehensive Income (Loss), Net of Tax, Total | $ 160 | $ (755) | 4,620 | $ 6,904 |
Other comprehensive (income) loss, net of tax, attributable to noncontrolling interests | 0 | 47 | 0 | (118) |
Accumulated other comprehensive income (loss) | (2,344) | (2,344) | ||
Accumulated Net Investment Gain (Loss) Attributable to Parent | ||||
Accumulated other comprehensive income (loss) | (2,504) | 4,054 | (6,964) | (3,440) |
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax | 627 | (182) | 5,305 | 8,522 |
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax | 467 | 573 | 685 | 1,618 |
Other Comprehensive Income (Loss), Net of Tax, Total | 160 | (755) | 4,620 | 6,904 |
Other comprehensive (income) loss, net of tax, attributable to noncontrolling interests | 0 | 47 | 0 | (118) |
Unrealized Gains/Losses Purchased from Noncontrolling Interests | 0 | 102 | 0 | 102 |
Accumulated other comprehensive income (loss) | $ (2,344) | $ 3,448 | $ (2,344) | $ 3,448 |
Stockholders' Equity Note Dis77
Stockholders' Equity Note Disclosure [Text Block]: Reclassification out of Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Gain (Loss) on Investments, Excluding Other than Temporary Impairments | $ 715 | $ 2,367 | $ 987 | $ 3,945 |
Net impairment losses recognized in earnings | 0 | 1,475 | 0 | 1,475 |
Income taxes (benefits) | 2,666 | 2,636 | (5,175) | 8,566 |
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total | 5,213 | 4,366 | 24,529 | 124,669 |
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Net Investment Gain (Loss) Attributable to Parent | ||||
Gain (Loss) on Investments, Excluding Other than Temporary Impairments | 719 | 2,446 | 1,062 | 4,067 |
Net impairment losses recognized in earnings | 0 | 1,475 | 0 | 1,475 |
Income (loss) before income taxes | 719 | 971 | 1,062 | 2,592 |
Income taxes (benefits) | 252 | 398 | 377 | 974 |
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total | $ 467 | $ 573 | $ 685 | $ 1,618 |
Compensation and Employee Ben78
Compensation and Employee Benefit Plans [Text Block] (Details) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2017USD ($)shares | Sep. 30, 2016USD ($) | Sep. 30, 2017USD ($)$ / sharesshares | Sep. 30, 2016USD ($)shares | Dec. 31, 2016USD ($)shares | |
Independence Holding Company Share Based Plans Total Member | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 1,099,100 | 1,099,100 | |||
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense | $ 145 | $ 16 | $ 218 | $ 255 | |
Independence Holding Company Share Based Plans Total Member | Selling, General and Administrative Expenses | |||||
Allocated Share-based Compensation Expense | 364 | (41) | $ 546 | $ 640 | |
Independence Holding Company Share Based Plans Total Member | Employee Stock Option | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 3 years | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares | $ 7.01 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 34,000 | 0 | |||
Proceeds from Stock Options Exercised | $ 0 | $ 84 | |||
Payments Related to Tax Withholding for Share-based Compensation | 303 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | 621 | 67 | |||
Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options | 180 | 15 | |||
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options | 537 | $ 537 | |||
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized, Period For Recognition 1 | 2 years 3 months 18 days | ||||
Independence Holding Company Share Based Plans Total Member | Employee Stock Option | Selling, General and Administrative Expenses | |||||
Allocated Share-based Compensation Expense | $ 36 | 0 | $ 106 | 170 | |
Independence Holding Company Share Based Plans Total Member | Employee Stock Option | Maximum | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 10 years | ||||
Independence Holding Company Share Based Plans Total Member | Stock Appreciation Rights (SARs) | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | shares | 30,800 | 30,800 | 71,500 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised | shares | 40,700 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities Paid | $ 676 | ||||
Independence Holding Company Share Based Plans Total Member | Stock Appreciation Rights (SARs) | Selling, General and Administrative Expenses | |||||
Allocated Share-based Compensation Expense | $ 305 | (57) | 359 | 410 | |
Independence Holding Company Share Based Plans Total Member | Stock Appreciation Rights (SARs) | Accounts Payable and Accrued Liabilities | |||||
Deferred Compensation Share-based Arrangements, Liability, Current and Noncurrent | 559 | $ 559 | $ 876 | ||
Independence Holding Company Share Based Plans Total Member | Stock Appreciation Rights (SARs) | Maximum | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 10 years | ||||
Independence Holding Company Share Based Plans Total Member | Restricted Stock Units (RSUs) | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 3 years | ||||
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized, Period For Recognition 1 | 1 year 9 months 18 days | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | $ 94 | 120 | |||
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Share-based Awards Other than Options | 153 | 153 | |||
Independence Holding Company Share Based Plans Total Member | Restricted Stock Units (RSUs) | Selling, General and Administrative Expenses | |||||
Allocated Share-based Compensation Expense | $ 23 | 16 | $ 81 | $ 60 | |
Independence Holding Company Share Based Plans Total Member | Modified Stock Option Awards Member | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Number of Employees Affected | 13 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Incremental Compensation Cost | $ 170 | ||||
American Independence Corp Share Based Plans Total Member | |||||
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense | 4 | 7 | |||
American Independence Corp Share Based Plans Total Member | Selling, General and Administrative Expenses | |||||
Allocated Share-based Compensation Expense | $ 7 | 14 | |||
American Independence Corp Share Based Plans Total Member | Employee Stock Option | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | 212 | ||||
Proceeds and Excess Tax Benefit from Share-based Compensation | $ 262 |
Compensation and Employee Ben79
Compensation and Employee Benefit Plans [Text Block]: Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan (Details) - Independence Holding Company Share Based Plans Total Member - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense | $ 145 | $ 16 | $ 218 | $ 255 |
Allocated Share-based Compensation Expense, Net of Tax | 219 | (25) | 328 | 385 |
Selling, General and Administrative Expenses | ||||
Allocated Share-based Compensation Expense | 364 | (41) | 546 | 640 |
Employee Stock Option | Selling, General and Administrative Expenses | ||||
Allocated Share-based Compensation Expense | 36 | 0 | 106 | 170 |
Restricted Stock Units (RSUs) | Selling, General and Administrative Expenses | ||||
Allocated Share-based Compensation Expense | 23 | 16 | 81 | 60 |
Stock Appreciation Rights (SARs) | Selling, General and Administrative Expenses | ||||
Allocated Share-based Compensation Expense | $ 305 | $ (57) | $ 359 | $ 410 |
Compensation and Employee Ben80
Compensation and Employee Benefit Plans [Text Block]: Schedule of Share-based Compensation, Stock Options, Activity (Details) - Independence Holding Company Share Based Plans Total Member - Employee Stock Option - $ / shares | 9 Months Ended | |
Sep. 30, 2017 | Sep. 30, 2016 | |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number | 697,180 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | $ 11.75 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 34,000 | 0 |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ 22.20 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 38,800 | |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $ 9.09 | |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number | 692,380 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | $ 12.41 |
Compensation and Employee Ben81
Compensation and Employee Benefit Plans [Text Block]: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) - Independence Holding Company Share Based Plans Total Member - Employee Stock Option | 9 Months Ended |
Sep. 30, 2017 | |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | 171.00% |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | 79.00% |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate | 3757.00% |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term | 4 years 6 months |
Compensation and Employee Ben82
Compensation and Employee Benefit Plans [Text Block]: Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding (Details) - Independence Holding Company Share Based Plans Total Member - Employee Stock Option $ / shares in Units, $ in Thousands | 9 Months Ended |
Sep. 30, 2017USD ($)$ / sharesshares | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 692,380 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares | 501,380 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | $ / shares | $ 12.41 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | $ / shares | $ 9.39 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | $ | $ 8,889 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | $ | $ 7,953 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term | 1 year 10 months 24 days |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term | 1 year |
Compensation and Employee Ben83
Compensation and Employee Benefit Plans [Text Block]: Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity (Details) - Independence Holding Company Share Based Plans Total Member - Restricted Stock Units (RSUs) - $ / shares | 9 Months Ended | |
Sep. 30, 2017 | Dec. 31, 2016 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | 17,325 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ 17.68 | $ 16.20 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | 4,950 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ 12.53 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | 12,375 |
Cash Flow, Supplemental Discl84
Cash Flow, Supplemental Disclosures [Text Block] (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2017 | Sep. 30, 2016 | |
Details | ||
Income Taxes Paid (Refunds), Net | $ 292 | $ 11,312 |
Interest Paid | $ 0 | $ 1,422 |
Commitments and Contingencies85
Commitments and Contingencies Disclosure [Text Block] (Details) - Pending Litigation $ in Thousands | 1 Months Ended |
May 31, 2017USD ($) | |
Loss Contingency, Nature, Injunctive Relief and Damages Member | |
Loss Contingency, Damages Sought, Value | $ 50,000 |
Loss Contingency, Nature, Amounts Allegedly Owed To Plaintiff Member | |
Loss Contingency, Damages Sought, Value | $ 3,082 |
Segment Reporting Disclosure 86
Segment Reporting Disclosure [Text Block]: Schedule of Segment Reporting Information, by Segment (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Revenues | $ 83,752 | $ 78,542 | $ 237,829 | $ 232,133 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | 7,879 | 7,002 | 19,354 | 23,323 |
Amortization of Intangible Assets | 393 | 366 | 941 | 1,057 |
Operating Segments | ||||
Revenues | 83,037 | 77,650 | 236,842 | 229,663 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | 7,164 | 6,550 | 18,367 | 22,219 |
Segment Reconciling Items | Net realized investment gains | ||||
Revenues | 715 | 2,367 | 987 | 3,945 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | 715 | 2,367 | 987 | 3,945 |
Segment Reconciling Items | Net Impairment Losses Recognized In Earnings | ||||
Revenues | 0 | (1,475) | 0 | (1,475) |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | 0 | (1,475) | 0 | (1,475) |
Segment Reconciling Items | Interest Expense | ||||
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | 0 | (440) | 0 | (1,366) |
Specialty Health Segment Member | ||||
Revenues | 55,502 | 44,684 | 152,292 | 126,454 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | 5,238 | 1,369 | 9,412 | 3,754 |
Amortization of Intangible Assets | 393 | 366 | 941 | 1,057 |
Group disability, life and DBL Segment Member | ||||
Revenues | 26,112 | 26,196 | 78,985 | 77,409 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | 5,144 | 5,323 | 12,777 | 13,533 |
Individual life annuities and other Segment Member | ||||
Revenues | 455 | 717 | 1,494 | 2,053 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | (385) | (410) | (532) | (1,888) |
Amortization of Other Deferred Charges | 368 | 296 | 937 | 1,949 |
Medical Stop-Loss Segment Member | ||||
Revenues | 576 | 5,433 | 2,549 | 21,397 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | (538) | 2,176 | 2,752 | 13,926 |
Corporate Segment | ||||
Revenues | 392 | 620 | 1,522 | 2,350 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $ (2,295) | $ (1,908) | $ (6,042) | $ (7,106) |